Monoamine oxidase A inhibitors

MAOI_A

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N06AG 1 out of 7 registries used, show all original rules.	5831
4. Check minimum number of events Min. number of events 3	5831
5. Include endpoints None	5831
6. Filter based on genotype QC (FinnGen only)	5271

Control definitions (FinnGen only)

Control exclude: ANTIDEPRESSANTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	MAOI_A
CONTROL_EXCLUDE	ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N06AG
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Monoamine oxidase A inhibitors based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5271	3196	2075
Unadjusted period prevalence (%)	1.06	1.13	0.95
Median age at first event (years)	44.45	43.60	45.76

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5384: Matched controls
53840

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

6.8

320.9

536

867

N06AA22, ,

ATC

148.9

318.8

159

N03AX16

ATC

[U] pregabalin

3.3

313.4

1584

6059

P01

ICPC

Feeling anxious/nervous/tense

7.3

307.7

947

1533

F32.9

ICD-10 Finland

Depressive episode, unspecified

28.0

307.7

1579

786

N06AG02

ATC

moclobemide; oral

+∞

307.7

5384

157

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

106.6

307.7

321

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

32.5

307.7

295

N05AX12

ATC

aripiprazole; systemic

32.8

307.7

525

177

N06AB08

ATC

fluvoxamine; oral

81.8

307.7

538

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

44.9

307.7

333

N03AG01

ATC

valproic acid; systemic, rectal

11.0

307.7

646

660

C07AA05

ATC

propranolol; systemic

5.4

307.7

1837

4673

SPAT1240

SPAT

Therapeutic discussion

6.5

307.7

753

1308

N05AA02

ATC

levomepromazine; systemic

26.8

307.7

579

241

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

11.2

307.7

865

901

N06AX03

ATC

mianserin; oral

80.6

307.7

979

148

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

21.1

307.7

265

132

F33

ICD-10 Finland

Recurrent depressive disorder

71.4

307.7

265

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

95.3

307.7

193

F32

ICD-10 Finland

Depressive episode

27.2

307.7

563

230

P99

ICPC

Psychological disorders other

17.7

307.7

309

185

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

26.3

307.7

246

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

86.9

307.7

233

N06AX12

ATC

bupropion; oral

71.0

307.7

1050

183

N06AB06

ATC

sertraline; oral

55.0

307.7

1678

440

N05BA04

ATC

oxazepam; oral

12.0

307.7

2843

4580

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

71.0

307.7

936

159

N06AX16

ATC

venlafaxine; oral

65.2

307.7

2119

531

N05AF03

ATC

chlorprothixene; systemic

37.0

307.7

408

119

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

24.6

307.7

357

155

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

92.9

307.7

171

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

156.9

307.7

709

P74

ICPC

Anxiety disorder/anxiety state

16.5

307.7

437

287

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

84.5

307.7

471

P03

ICPC

Feeling depressed

14.0

307.7

968

831

N06AA12

ATC

doxepin; systemic

30.8

307.7

702

261

N06AA04

ATC

clomipramine; systemic

87.9

307.7

299

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

18.6

307.7

992

646

F31.8

ICD-10 Finland

Other bipolar affective disorders

53.3

307.7

210

N07BB01

ATC

disulfiram; oral

11.9

307.7

405

365

N05BA12

ATC

alprazolam; oral

19.5

307.7

1532

1076

F41.1

ICD-10 Finland

Generalized anxiety disorder

21.5

307.7

553

285

N06AX22

ATC

agomelatine; oral

193.4

307.7

361

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

176.6

307.7

347

F51.0

ICD-10 Finland

Nonorganic insomnia

4.6

307.7

1197

3178

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

8.6

307.7

814

1090

P76

ICPC

Depressive disorder

33.0

307.7

795

281

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

21.0

307.7

361

184

N05CF02

ATC

zolpidem; oral

5.4

307.7

1425

3375

N06AB03

ATC

fluoxetine; oral

46.0

307.7

1970

667

T36

ICD-10 Finland

Poisoning by systemic antibiotics

18.9

307.7

487

282

IGY02

NOMESCO Finland

Psychiatric monitoring contact

17.4

307.7

293

178

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

164.9

307.7

974

N05AB03

ATC

perphenazine; systemic, rectal

24.6

307.7

533

239

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

12.2

307.7

936

914

N03AE01

ATC

clonazepam; systemic

11.4

307.7

685

679

N06AX18

ATC

reboxetine; oral

290.8

307.7

302

N05BE01

ATC

buspirone; oral

81.4

307.7

652

N06AX05

ATC

trazodone; oral

89.9

307.7

392

N05AH03

ATC

olanzapine; systemic

17.7

307.7

764

499

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

25.2

307.7

239

F32.1

ICD-10 Finland

Moderate depressive episode

20.3

307.7

631

349

N05CD07

ATC

temazepam; oral

13.5

307.7

1456

1440

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

15.9

307.7

378

254

N06AB05

ATC

paroxetine; oral

56.0

307.7

991

216

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

85.0

307.7

335

N06AA09

ATC

amitriptyline; systemic

10.6

307.7

921

1031

N06AB10

ATC

escitalopram; oral

29.2

307.7

2167

1215

N06AX17

ATC

milnacipran; oral

168.9

307.7

211

N05AX08

ATC

risperidone; systemic

9.5

307.7

801

974

N06CA01

ATC

amitriptyline and psycholeptics; systemic

7.7

307.7

1018

1587

N06AX26

ATC

vortioxetine; oral

79.4

307.7

988

152

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

137.6

307.7

186

N05CF01

ATC

zopiclone; oral

6.6

307.7

2784

7468

N06AA06

ATC

trimipramine; systemic

46.9

307.7

380

N05AN01

ATC

lithium; oral

37.6

307.7

385

110

N05AF01

ATC

flupentixol; systemic

50.0

307.7

329

N06AX11

ATC

mirtazapine; oral

13.9

307.7

3198

5125

F40.1

ICD-10 Finland

Social phobias

55.1

307.7

413

N03AX09

ATC

lamotrigine; oral

30.2

307.7

671

253

N05BA01

ATC

diazepam; systemic, rectal

10.3

307.7

1545

2034

F34.1

ICD-10 Finland

Dysthymia

105.1

307.7

656

N06AX21

ATC

duloxetine; oral

21.8

307.7

1372

830

N05AH04

ATC

quetiapine; oral

19.0

307.7

2091

1741

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

42.7

307.7

237

F61.0

ICD-10 Finland

Mixed personality disorders

104.6

307.7

278

N05AL01

ATC

sulpiride; systemic

62.0

307.7

288

N06AB04

ATC

citalopram; systemic

40.3

307.7

2688

1301

P29

ICPC

Psychological sympt/compl other

8.4

307.7

651

869

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

309.1

307.7

858

N05BA02

ATC

chlordiazepoxide; systemic

24.3

307.7

312

136

N05BA06

ATC

lorazepam; systemic, sublingual

13.1

307.7

590

503

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

29.1

307.7

947

392

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

75.8

307.7

253

IHZ05, ,

SPAT

10.3

297.4

340

349

F60.9

ICD-10 Finland

Personality disorder, unspecified

43.5

296.9

177

F41.09

ICD-10 Finland

UNS Panic Syndrome

19.4

296.9

233

125

IGY99

NOMESCO Finland

Other psychiatric treatment contact

27.0

295.9

203

ZY010

NOMESCO Finland

Hospital outpatient

7.1

290.8

459

698

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

61.4

279.1

155

N05CD02

ATC

nitrazepam; oral

17.8

267.9

219

128

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

108.1

266.7

137

F31

ICD-10 Finland

Bipolar affective disorder

48.3

266.4

155

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

31.1

263.2

172

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

41.7

262.4

158

P06

ICPC

Sleep disturbance

3.8

262.0

923

2776

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

11.4

255.0

271

250

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

22.4

252.5

186

F41.00

ICD-10 Finland

Moderate panic disorder

42.8

250.8

150

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

12.6

250.5

249

207

F10.20

ICD-10 Finland

Alcohol dependence currently independent

18.3

243.3

196

111

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

46.0

236.3

139

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

5.9

234.8

443

804

R53

ICD-10 Finland

Malaise and fatigue

2.8

234.3

1577

6930

N05AB01

ATC

dixyrazine; systemic

27.3

232.9

159

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

67.3

228.6

125

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

30.4

224.9

148

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

12.9

224.9

219

176

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

52.4

223.8

128

Z2445

NOMESCO Finland

Psychologist

8.1

221.9

306

398

N05AC02

ATC

thioridazine; oral

13.9

220.8

206

154

N06BA04

ATC

methylphenidate; oral

12.5

213.3

212

176

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

16.1

211.9

182

117

SPAT1307

SPAT

Psychosocial counselling and guidance

6.4

211.6

363

599

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

208.1

1711

8234

N05BA05

ATC

potassium clorazepate; oral

27.1

204.7

140

F99

ICD-10 Finland

Mental disorder, not otherwise specified

14.1

203.6

188

138

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

8.1

203.4

280

363

V03AA01, ,

ATC

16.8

203.0

170

104

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

21.4

202.9

152

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.4

201.3

833

2756

F32.8

ICD-10 Finland

Other depressive episodes

22.9

199.1

145

F29

ICD-10 Finland

Unspecified nonorganic psychosis

8.5

196.1

257

314

SPAT1243

SPAT

Psychiatric/psychological examination

13.2

195.2

187

146

F60.5

ICD-10 Finland

Anankastic personality disorder

43.9

195.1

116

N03AX12

ATC

[U] gabapentin; oral

3.0

192.7

991

3724

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

85.8

191.2

101

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

17.1

187.6

156

IGY02, ,

SPAT

18.6

181.9

145

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

25.0

180.4

127

A03CA02

ATC

clidinium and psycholeptics; oral

4.6

179.4

458

1076

F41.8

ICD-10 Finland

Other specified anxiety disorders

9.0

178.7

223

256

Z2446

NOMESCO Finland

Social worker

4.5

177.4

456

1077

IHZ04, ,

SPAT

15.4

175.4

154

103

N05AD03

ATC

melperone; systemic

16.8

175.3

147

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

6.5

174.2

294

476

A02BA02

ATC

ranitidine; systemic

2.6

172.4

1203

5283

F39

ICD-10 Finland

Unspecified mood [affective] disorder

16.8

171.9

144

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

21.8

169.8

126

N04AA02

ATC

biperiden; systemic

12.9

168.8

164

131

N06AA10

ATC

nortriptyline; systemic

11.9

168.2

172

149

F90.0

ICD-10 Finland

Disturbance of activity and attention

9.4

166.7

202

223

A04

ICPC

Weakness/tiredness general

2.8

164.7

971

3906

G47.3

ICD-10 Finland

Sleep apnoea

2.4

164.1

1449

7088

A06AD11

ATC

lactulose; oral

3.0

163.4

862

3265

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

15.8

158.4

137

P15

ICPC

Chronic alcohol abuse

7.8

158.0

223

297

N05AA01

ATC

chlorpromazine; systemic, rectal

16.1

150.9

129

F10.24

ICD-10 Finland

Alcohol depence active use

16.0

149.1

128

F41.3

ICD-10 Finland

Other mixed anxiety disorders

18.4

148.8

119

A02BC01

ATC

omeprazole; systemic

2.3

148.0

1587

8384

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.7

147.8

357

800

M79.7

ICD-10 Finland

Fibromyalgia

6.7

146.0

236

365

N02BF02

ATC

pregabalin; oral

3.9

145.1

462

1275

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

34.8

140.9

N02AX02

ATC

tramadol; systemic, rectal

2.1

140.5

2418

15264

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

32.7

139.9

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

139.6

1634

8911

F60.8

ICD-10 Finland

Other specific personality disorders

53.4

138.5

A03FA02

ATC

cisapride; oral, rectal

3.5

136.3

510

1567

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

12.7

136.2

133

107

V03AB30, ,

ATC

31.9

135.9

A02BC03

ATC

lansoprazole; oral

2.2

134.6

1656

9186

F32.0

ICD-10 Finland

Mild depressive episode

9.2

134.1

164

183

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

160.8

134.0

141

N05AB02

ATC

fluphenazine; systemic

26.4

132.1

N03AX11

ATC

topiramate; oral

7.8

131.2

185

246

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

9.3

130.8

159

176

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.1

130.0

231

393

F10.25

ICD-10 Finland

Alcohol dependence continuous use

11.2

129.4

137

125

R06.0

ICD-10 Finland

Dyspnoea

2.1

128.4

1574

8692

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

324.6

127.0

128

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

124.9

2062

12681

N03AF01

ATC

carbamazepine; oral, rectal

4.3

123.4

333

813

N05AE04

ATC

ziprasidone; systemic

67.8

122.4

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

23.9

121.6

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

12.1

121.2

122

103

Z3231

NOMESCO Finland

Registered nurse

2.1

120.6

1537

8580

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.0

119.9

596

2165

F43.1

ICD-10 Finland

Post-traumatic stress disorder

8.4

119.7

158

194

H03AA01

ATC

levothyroxine sodium; systemic

2.2

118.8

1382

7444

A02BC02

ATC

pantoprazole; systemic

2.0

118.5

3784

28952

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

118.2

2065

12891

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

116.8

1636

9440

A02BC05

ATC

esomeprazole; systemic

1.9

116.4

2288

14847

N06AC02, ,

ATC

59.8

116.3

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.8

115.5

368

1013

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

4.7

114.7

275

611

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

8.7

114.0

145

170

ZY000

NOMESCO Finland

Hospital inpatient

13.5

113.5

107

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

15.6

112.9

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

22.2

112.7

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

33.2

112.4

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

22.5

112.0

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

23.2

110.6

Z2221

NOMESCO Finland

Medical doctor

2.0

108.2

1548

8956

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

52.3

108.1

AA400

NOMESCO Finland

Electroconvulsive therapy

144.2

106.5

113

IAB01, ,

SPAT

32.8

105.8

N05CD08

ATC

midazolam; nasal, systemic

6.5

105.8

176

280

R03AC02

ATC

salbutamol; inhalant

1.9

104.7

2966

21398

A02BA04

ATC

nizatidine; systemic

3.1

104.4

470

1610

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

31.3

104.3

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

20.5

103.9

IEY01

NOMESCO Finland

Psychoeducation, individual

32.3

103.8

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

103.5

1604

9518

IER01

NOMESCO Finland

Psychoeducation, group

29.9

102.9

R4140

NOMESCO Finland

Psychotherapy

34.6

102.7

F33.8

ICD-10 Finland

Other recurrent depressive disorders

214.1

101.9

105

AA1AD

NOMESCO Finland

CT of head and brain

2.0

101.8

1541

9061

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

32.9

101.2

J02AC01

ATC

fluconazole; systemic

1.9

100.6

2181

14417

IBA03

NOMESCO Finland

Psychotherapy evaluation

22.4

99.6

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

23.2

98.2

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

34.8

98.1

IGV01

NOMESCO Finland

Psychiatric network contact

20.8

97.9

ICB06, ,

NOMESCO Finland

36.3

97.6

M03BX02

ATC

tizanidine; oral

1.8

97.6

3373

25627

F60.7

ICD-10 Finland

Dependent personality disorder

48.0

97.6

C07AB07

ATC

bisoprolol; oral

1.8

97.3

2576

18050

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.7

97.2

326

928

N05AD01

ATC

haloperidol; systemic

5.4

95.5

193

370

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.4

95.0

114

124

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.6

94.5

334

984

9690A

ICD-9 Finland

Poisoning by psychotropic agents, Antidepressants

43.5

93.8

N05AC01

ATC

periciazine; systemic

30.8

93.1

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

19.0

92.7

A01

ICPC

Pain general/multiple sites

2.6

92.3

594

2455

Z3226

NOMESCO Finland

Physiotherapist

2.1

91.4

993

5148

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

36.0

91.0

P16

ICPC

Acute alcohol abuse

9.1

90.9

112

126

188

Kela drug reimbursment

Psychosis requiring demanding treatment

12.8

90.6

L28

ICPC

Limited function/disability (L)

2.1

90.5

1013

5311

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.3

89.3

360

1152

R42

ICD-10 Finland

Dizziness and giddiness

2.0

89.1

1271

7272

P25

ICPC

Phase of life problem adult

4.2

89.1

241

588

P28

ICPC

Limited function/disability (P)

16.2

88.2

Z71.8

ICD-10 Finland

Other specified counselling

1.8

87.7

1865

12127

N04BC05

ATC

pramipexole; oral

2.9

87.2

430

1547

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

87.0

2326

16172

N05AH02

ATC

clozapine; systemic

9.0

86.5

107

121

M03BC51

ATC

orphenadrine, combinations; systemic

1.9

86.4

1465

8865

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

118.3

86.2

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

40.4

85.5

N05CD05

ATC

triazolam; oral, sublingual

9.4

85.5

102

110

ZYC01

NOMESCO Finland

Remote contact by phone

3.0

85.2

399

1394

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

45.9

84.7

M01AG02

ATC

tolfenamic acid; oral, rectal

2.2

84.0

831

4141

P73

ICPC

Affective psychosis

27.4

83.7

G04BD04

ATC

oxybutynin; oral, transdermal

3.4

83.4

308

933

G44.2

ICD-10 Finland

Tension-type headache

2.3

83.1

751

3607

F41.01

ICD-10 Finland

Severe panic disorder

42.0

83.0

N02BF01

ATC

gabapentin; oral

2.5

82.9

587

2534

P01AB01

ATC

metronidazole; oral, rectal

1.8

82.8

2145

14719

E66.8

ICD-10 Finland

Other obesity

3.3

82.4

328

1041

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.1

81.7

364

1235

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

9.1

81.4

100

112

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.5

81.4

545

2290

R51.80

ICD-10 Finland

Headache

2.2

80.6

815

4092

L03

ICPC

Low back symptom/complaint

1.8

80.2

1570

9900

M54.5

ICD-10 Finland

Low back pain

1.8

79.4

1929

12956

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

78.6

363

1257

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

78.5

1035

5731

R5140

NOMESCO Finland

Monitoring the use of the aid

2.3

78.5

645

2972

F61

ICD-10 Finland

Mixed and other personality disorders

108.0

78.1

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

77.9

1227

7213

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

77.9

545

2337

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

6.6

77.3

126

196

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

77.2

468

1873

IGY99, ,

SPAT

8.0

77.0

105

134

309

Kela drug reimbursment

Nalmefene and naltrexone

31.5

76.8

R06AE07

ATC

cetirizine; oral

1.7

76.6

2317

16496

R02

ICPC

Shortness of breath/dyspnoea

2.2

76.6

762

3797

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

162.4

76.2

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

9.9

74.9

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

74.2

1980

13590

L17

ICPC

Foot/toe symptom/complaint

1.8

73.8

1665

10898

M79.6

ICD-10 Finland

Pain in limb

1.7

73.6

2362

17028

E66.01

ICD-10 Finland

Obesity due to excess calories

2.5

73.5

526

2276

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

11.7

73.1

T82

ICPC

Obesity

3.5

73.1

267

802

R52.2

ICD-10 Finland

Other chronic pain

3.9

72.5

219

579

F21

ICD-10 Finland

Schizotypal disorder

20.6

72.4

M01AE02

ATC

naproxen; oral, rectal

1.7

72.0

2922

22347

SPAT1234

SPAT

Support of social functional capacity

3.5

71.9

253

742

J01DA01

ATC

[U] cefalexin

1.7

71.9

3219

25256

C03CA01

ATC

furosemide; systemic

1.8

71.4

1446

9156

P20

ICPC

Memory disturbance

2.2

71.4

686

3366

K59.0

ICD-10 Finland

Constipation

3.1

71.0

318

1081

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

70.6

795

4144

P72

ICPC

Schizophrenia

6.6

70.5

114

176

SPAT1241

SPAT

Extensive assessment of psychosocial situation

12.5

70.1

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

70.1

2255

16203

ZXE00

NOMESCO Finland

One hour or less

1.7

69.4

1975

13732

D01

ICPC

Abdominal pain/cramps general

2.2

69.1

684

3393

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

148.0

69.1

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

68.7

1838

12560

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

36.1

68.6

IBA01, ,

SPAT

6.5

68.5

113

178

L01

ICPC

Neck symptom/complaint

2.0

68.4

898

4942

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

67.9

726

3708

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

6.2

67.7

116

190

F41

ICD-10 Finland

Other anxiety disorders

6.8

67.3

105

156

F10.09

ICD-10 Finland

Alcohol intoxication UNS

5.9

66.8

120

206

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

29.6

66.2

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

66.1

3752

30968

A97

ICPC

No disease

1.9

66.1

1086

6430

R06.5

ICD-10 Finland

Mouth breathing

2.3

65.2

512

2306

30041

ICD-8 Finland

Neuroses, Depressiva

8.4

65.0

103

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

64.9

2282

16670

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

64.9

1158

7031

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

5.4

64.5

129

245

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

64.3

729

3802

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.7

64.1

151

330

ZXY60

NOMESCO Finland

2-person team, nurses

30.2

63.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

63.5

1211

7493

SFA10

NOMESCO Finland

One-surface restoration

1.6

63.4

2871

22273

D11

ICPC

Diarrhoea

2.2

63.1

622

3074

G04BD12

ATC

mirabegron; oral

2.1

62.8

637

3183

R03BB04

ATC

tiotropium bromide; inhalant

2.3

62.5

506

2307

A28

ICPC

Limited function/disability NOS

2.0

62.5

835

4612

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

62.0

309

1114

F51

ICD-10 Finland

Nonorganic sleep disorders

3.5

62.0

215

624

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

133.6

62.0

R01AD09

ATC

mometasone; nasal

1.6

61.7

2329

17249

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

29.5

61.6

A01AB09

ATC

miconazole; local oral

2.4

61.4

452

1976

N02BE01

ATC

paracetamol; systemic, rectal

2.0

61.4

4742

42230

E0000UV, ,

ATC

1.6

61.4

2150

15629

L02

ICPC

Back symptom/complaint

2.2

61.4

564

2710

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.9

61.3

111

192

S06.0

ICD-10 Finland

Concussion

2.2

61.3

543

2571

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

9.0

61.1

WX290

NOMESCO Finland

Other blockage of nerve

1.6

60.9

2398

17924

ZXY49

NOMESCO Finland

Other health care provider

26.4

60.8

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

60.8

686

3566

R06AX13

ATC

loratadine; oral

2.0

60.7

797

4373

R4110

NOMESCO Finland

Physiotherapy

1.7

60.7

1469

9707

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

13.4

60.5

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

129.5

59.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

59.9

2425

18219

R25.1

ICD-10 Finland

Tremor, unspecified

3.7

59.9

197

552

G04BD07

ATC

tolterodine; oral

3.1

59.8

262

879

J01MA02

ATC

ciprofloxacin; systemic

1.6

59.7

1953

13935

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

59.5

3718

30967

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

59.5

898

5159

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.7

59.2

110

195

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

58.6

654

3383

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

58.5

499

2324

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

58.3

946

5557

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

74.4

58.2

Z01.2

ICD-10 Finland

Dental examination

1.6

58.0

2430

18361

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.5

57.8

381

1582

J01FA06

ATC

roxithromycin; oral

1.6

57.6

2020

14624

R01AD08

ATC

fluticasone; nasal

1.7

57.6

1470

9827

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

57.5

1392

9174

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

9.7

57.5

UJF32

NOMESCO Finland

Coloscopy

1.7

57.3

1346

8797

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

8.2

57.2

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

57.0

519

2481

ICB01, ,

SPAT

11.5

56.9

J01EA01

ATC

trimethoprim; systemic

1.7

56.7

1289

8346

R03BA02

ATC

budesonide; inhalant

1.8

56.6

927

5456

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

20.6

56.6

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.8

56.3

174

467

R01BA52

ATC

pseudoephedrine, combinations; oral

1.7

56.3

1574

10763

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

56.0

371

1544

IAA01, ,

SPAT

11.5

56.0

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

18.1

56.0

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

89.7

56.0

K02.1

ICD-10 Finland

Caries of dentine

1.6

55.9

3003

23947

J01AA02

ATC

doxycycline; systemic

1.7

55.9

4085

35068

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

55.8

2075

15202

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

10.1

55.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.7

55.7

1472

9914

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

55.5

1545

10542

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

55.5

501

2387

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

9.0

55.4

R52.9

ICD-10 Finland

Pain, unspecified

2.1

55.4

566

2831

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

54.8

352

1443

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

54.5

2235

16726

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

54.4

2834

22385

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

54.1

2336

17677

N06BA12

ATC

lisdexamfetamine; oral

12.4

53.8

A09

ICPC

Sweating problem

6.2

53.6

151

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

53.6

547

2733

N17

ICPC

Vertigo/dizziness

2.0

53.5

672

3620

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

53.4

627

3298

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

53.3

1198

7717

A07DA03

ATC

loperamide; oral

3.3

53.0

201

618

C07AB02

ATC

metoprolol; systemic

1.8

53.0

946

5706

A06AC51

ATC

ispaghula, combinations; oral

2.8

52.4

271

996

M01AH01

ATC

celecoxib; oral

1.8

52.3

914

5474

N01

ICPC

Headache

2.1

52.3

519

2564

M02AA07

ATC

piroxicam; topical

1.6

52.0

1799

12904

S29

ICPC

Skin symptom/complaint other

1.7

52.0

1085

6841

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

51.9

915

5493

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

96.1

51.9

C05AA08

ATC

fluocortolone; rectal, topical

1.9

51.8

719

4005

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

51.2

833

4879

SPAT1238

SPAT

Brief therapy

7.1

51.2

110

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

263.1

51.2

SPAT1235

SPAT

Mental health, emotional support

14.5

51.0

N05AF05

ATC

zuclopenthixol; systemic

9.0

51.0

M01AB05

ATC

diclofenac; systemic, rectal

1.6

51.0

3405

28237

A10BA02

ATC

metformin; oral

1.6

51.0

1381

9325

EBA00

NOMESCO Finland

Extraction of tooth

1.6

50.7

1792

12899

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

11.7

50.7

H02AB06

ATC

prednisolone; systemic

1.5

50.7

2395

18403

U07

ICPC

Urine symptom/complaint other

2.2

50.5

472

2277

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

50.5

1544

10738

M01AX17

ATC

nimesulide; oral

1.7

50.5

1193

7773

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

9.2

50.4

R03AC03

ATC

terbutaline; inhalant

1.9

50.4

709

3965

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

50.3

1016

6340

E66.9

ICD-10 Finland

Obesity, unspecified

3.2

50.0

199

630

R35

ICD-10 Finland

Polyuria

2.4

50.0

363

1574

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

50.0

1880

13719

R06AX22

ATC

ebastine; oral

1.8

49.9

888

5341

A02BA03

ATC

famotidine; systemic

3.1

49.9

212

698

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

49.8

1731

12399

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

49.8

748

4270

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

49.3

825

4869

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

49.1

629

3406

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

49.0

962

5950

R03DC03

ATC

montelukast; oral

1.8

48.5

849

5079

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

14.3

48.5

P27

ICPC

Fear of mental disorder

8.4

48.4

J01MA06

ATC

norfloxacin; oral

1.9

48.3

680

3800

IHZ07, ,

SPAT

10.7

47.9

Z08

ICPC

Social welfare problem

6.8

47.9

112

T90

ICPC

Diabetes non-insulin dependent

1.7

47.8

1220

8095

A02BX02

ATC

sucralfate; oral

3.0

47.6

211

712

N02AA05

ATC

oxycodone; systemic

1.8

47.6

836

5004

F22.0

ICD-10 Finland

Delusional disorder

5.6

47.5

166

T83

ICPC

Overweight

3.8

47.4

146

391

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

11.5

47.3

D12

ICPC

Constipation

3.1

47.3

206

688

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

61.7

47.3

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

47.3

1383

9487

G04CA02

ATC

tamsulosin; oral

1.7

47.2

1007

6368

SFA20

NOMESCO Finland

Two-surface restoration

1.5

47.2

2991

24324

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

47.2

676

3798

N02AC04

ATC

dextropropoxyphene; oral

3.2

47.0

186

587

L08

ICPC

Shoulder symptom/complaint

1.6

46.9

1216

8094

IHZ02, ,

SPAT

8.5

46.8

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.3

46.4

360

1606

Z29

ICPC

Social problem NOS

4.6

46.4

112

250

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

6.9

46.1

104

F84.5

ICD-10 Finland

Asperger syndrome

16.4

46.1

R03BA05

ATC

fluticasone; inhalant

1.7

46.0

895

5513

P18

ICPC

Medication abuse

13.0

46.0

R52.1

ICD-10 Finland

Chronic intractable pain

7.9

45.9

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

45.8

1846

13612

XA800

NOMESCO Finland

Neuropsychological investigation

2.9

45.7

217

761

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

45.6

3369

28200

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

45.5

1249

8422

IHZ01, ,

SPAT

7.9

45.5

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.8

45.4

230

836

2961E

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN+PSYKOOT PIIRTEI]

59.4

45.3

F50.9

ICD-10 Finland

Eating disorder, unspecified

12.3

45.3

J01AA07

ATC

tetracycline; systemic

1.8

45.3

724

4207

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

45.3

1147

7581

F43.29

ICD-10 Finland

Adaptation disorder UNS

4.2

45.1

120

289

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

44.7

1293

8829

SPAT1301

SPAT

No procedures

1.6

44.5

1438

10078

M01AB55

ATC

diclofenac, combinations; oral

2.3

44.4

344

1533

SFA30

NOMESCO Finland

Three-surface restoration

1.5

44.4

2181

16747

H02AB07

ATC

prednisone; oral

1.9

44.3

674

3856

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

9.1

44.2

A99

ICPC

Disease/condition unspecnature/site

2.0

44.0

540

2876

N05AE05

ATC

lurasidone; oral

72.2

44.0

E000001, ,

ATC

1.7

44.0

939

5927

L29

ICPC

Musculoskeletal sympt/complt other

2.0

44.0

481

2460

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

43.9

1119

7400

J01DB01

ATC

cefalexin; oral

1.6

43.8

4259

37688

R07.3

ICD-10 Finland

Other chest pain

2.0

43.8

537

2860

KMAK, ,

NOMESCO Finland

1.5

43.7

2505

19831

SPAT1265

SPAT

Breathalyser

8.3

43.6

R11

ICD-10 Finland

Nausea and vomiting

2.2

43.5

410

1981

7290A

ICD-9 Finland

Other disorders of soft tissues, Rheumatism, unspecified and fibrositis

11.0

43.3

G25.0

ICD-10 Finland

Essential tremor

3.4

43.3

162

494

U02

ICPC

Urinary frequency/urgency

1.8

43.2

759

4532

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

63.1

43.2

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

43.2

1180

7936

SPAT1254

SPAT

Administration of medicine

1.9

43.1

627

3533

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.6

43.1

1200

8107

G04BD08

ATC

solifenacin; oral

2.4

43.1

318

1388

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

43.0

298

1264

SCA01

NOMESCO Finland

Preventive oral health care, short

1.6

43.0

1362

9486

Z72.1

ICD-10 Finland

Alcohol use

6.5

43.0

109

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

42.9

691

4019

R03BA01

ATC

beclometasone; inhalant

1.8

42.9

698

4073

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

42.9

693

4035

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.5

42.9

153

D07AA02

ATC

hydrocortisone; topical

1.8

42.8

659

3780

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

42.8

362

1674

A01AB04

ATC

amphotericin B; local oral

2.7

42.8

237

902

E66.00

ICD-10 Finland

Metabolic syndrome

2.4

42.7

302

1293

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

42.5

1221

8305

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

42.4

1129

7541

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

69.1

42.0

SPAT1053

SPAT

Memory test

1.9

41.7

599

3361

M54

ICD-10 Finland

Dorsalgia

1.9

41.5

614

3476

P58

ICPC

Psychological, Therapeutic counselling/listening

4.7

41.5

207

R05

ICPC

Cough

1.6

41.5

1247

8569

RS221, ,

NOMESCO Finland

5.2

41.4

169

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

41.3

659

3820

OAB38, ,

SPAT

5.5

41.2

148

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

41.2

421

2098

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

41.0

497

2633

N05AX15

ATC

cariprazine; oral

77.4

40.9

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

40.9

626

3582

A07AA02

ATC

nystatin; oral

2.4

40.9

298

1293

J01FA10

ATC

azithromycin; systemic

1.5

40.6

2837

23222

M79.1

ICD-10 Finland

Myalgia

1.8

40.6

731

4393

R06AX27

ATC

desloratadine; oral

1.6

40.3

1397

9906

SPAT1252

SPAT

Overall medication plan or its review

2.3

40.3

316

1415

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

400.5

40.1

M48.0

ICD-10 Finland

Spinal stenosis

1.9

40.1

570

3185

M01AC06

ATC

meloxicam; systemic, rectal

1.5

39.9

1787

13380

Z72.2

ICD-10 Finland

Drug use

14.5

39.9

R96

ICPC

Asthma

1.9

39.8

509

2747

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.7

39.7

221

843

UKC02

NOMESCO Finland

Cystoscopy

1.8

39.7

726

4379

J01DA06

ATC

[U] cefuroxime

1.8

39.7

709

4248

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.3

39.5

324

1479

D07AC01

ATC

betamethasone; topical

1.5

39.5

1816

13667

N03AF02

ATC

oxcarbazepine; oral

3.2

39.4

161

518

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

39.4

1177

8062

L15

ICPC

Knee symptom/complaint

1.6

39.2

1295

9077

F45.0

ICD-10 Finland

Somatization disorder

15.5

39.1

S18

ICPC

Laceration/cut

1.5

38.9

2348

18626

K30

ICD-10 Finland

Functional dyspepsia

1.9

38.8

578

3276

M01AH02

ATC

rofecoxib; oral

1.8

38.8

604

3472

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

38.8

423

2158

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

38.8

321

1471

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

38.7

1452

10462

R05

ICD-10 Finland

Cough

1.6

38.5

1098

7432

R01AD01

ATC

beclometasone; nasal

1.7

38.3

755

4650

P80

ICPC

Personality disorder

63.3

38.1

M01AE51

ATC

ibuprofen, combinations; systemic

4.4

38.1

226

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

38.0

1115

7597

N30.0

ICD-10 Finland

Acute cystitis

1.7

37.9

817

5152

C10AA01

ATC

simvastatin; oral

1.5

37.9

1918

14681

F33.3

ICD-10 Finland

Recurrent depressive disorder, current episode severe with psychotic symptoms

196.4

37.8

G03DB01

ATC

dydrogesterone; oral

1.8

37.8

614

3575

N07BA03

ATC

varenicline; oral

2.5

37.7

237

960

N05BB01

ATC

hydroxyzine; systemic

2.3

37.7

304

1378

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

37.6

423

2181

XKD00

NOMESCO Finland

Uroflowmetry

1.8

37.5

676

4056

IGP01

NOMESCO Finland

Psychiatric family contact

12.4

37.5

-, ,

ICD-10 Finland

3.4

37.3

134

398

SPAT1310

SPAT

Counselling related to known health issue

1.5

37.2

1444

10464

U04

ICPC

Incontinence urine

2.3

37.0

279

1228

R41.0

ICD-10 Finland

Disorientation, unspecified

3.3

37.0

140

430

D19

ICPC

Teeth/gum symptom/complaint

1.5

37.0

1550

11410

SPAT1260

SPAT

Consultation of another employee

1.7

36.7

798

5040

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

36.7

1819

13843

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

36.6

973

6469

SPAT1227

SPAT

Substance abuse rehabilitation

13.0

36.5

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

36.4

912

5975

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

36.3

739

4586

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

36.2

366

1814

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

2.4

36.2

251

1065

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

5.4

36.1

133

A27

ICPC

Fear of other disease NOS

2.3

36.1

270

1185

N05AB04

ATC

prochlorperazine; systemic, rectal

3.5

35.9

124

359

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

8.3

35.9

K10.3

ICD-10 Finland

Alveolitis of jaws

2.5

35.9

232

953

A02BC04

ATC

rabeprazole; oral

2.0

35.8

437

2319

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.5

35.6

1346

9683

M25.5

ICD-10 Finland

Pain in joint

1.5

35.6

1627

12172

K07.60

ICD-10 Finland

Snapping jaw

2.4

35.5

247

1049

R06AX26

ATC

fexofenadine; oral

2.1

35.5

356

1760

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

35.2

915

6044

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

10.3

35.1

E66

ICD-10 Finland

Obesity

2.3

35.1

280

1263

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.8

35.1

185

687

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

12.7

34.9

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

34.9

761

4808

J45

ICD-10 Finland

Asthma

1.9

34.8

511

2881

TAB00

NOMESCO Finland

Lumbar puncture

2.6

34.7

214

859

IAB07

NOMESCO Finland

Consultation concerning a patient with self-harm intention

124.2

34.7

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

34.7

1187

8351

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.9

34.7

168

596

-1, ,

NOMESCO Finland

1.5

34.4

1523

11304

L86

ICPC

Back syndrome with radiating pain

2.2

34.3

308

1459

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

34.2

260

1149

SPAT1216

SPAT

Assessment of functional ability

1.7

34.1

648

3940

R60.0

ICD-10 Finland

Localized oedema

1.7

34.0

620

3727

C10AC01

ATC

colestyramine; oral

3.0

33.9

148

495

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

33.8

1907

14817

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

33.8

650

3966

X15

ICPC

Vaginal symptom/complaint other

2.7

33.8

180

672

ZYC02, ,

SPAT

3.8

33.7

102

270

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

33.7

313

1502

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.1

33.6

146

487

SPAT1229

SPAT

Assessment of need for aid

2.1

33.5

328

1606

R01AD05

ATC

budesonide; nasal

2.0

33.4

379

1959

R21

ICPC

Throat symptom/complaint

1.6

33.4

939

6312

ZXD05

NOMESCO Finland

Urgent procedure

1.5

33.3

1353

9859

L12

ICPC

Hand/finger symptom/complaint

1.6

33.1

838

5493

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

63.7

33.0

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

33.0

1315

9540

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

33.0

599

3595

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

32.9

772

4964

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

90.7

32.7

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

32.7

713

4499

R74

ICPC

Upper respiratory infection acute

1.5

32.6

1516

11337

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

32.6

1837

14246

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

7.2

32.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

32.5

3318

28567

SPAT1139

SPAT

Nutrition survey

2.9

32.3

157

558

J45.1

ICD-10 Finland

Nonallergic asthma

2.0

32.3

345

1745

Z50.7

ICD-10 Finland

Occupational therapy and vocational rehabilitation, not elsewhere classified

8.6

32.2

XKD03

NOMESCO Finland

Urethral pressure profilometry

3.3

32.0

122

377

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

4.5

31.9

172

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

31.9

245

1087

L13

ICPC

Hip symptom/complaint

1.6

31.9

976

6683

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.9

31.8

156

557

R4120

NOMESCO Finland

Occupational therapy

2.1

31.8

319

1576

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

31.7

2517

20710

A29

ICPC

General symptom/complaint other

1.7

31.7

634

3908

J01CA04

ATC

amoxicillin; systemic

1.5

31.4

4116

36970

IHZ19, ,

SPAT

7.4

31.4

K08.3

ICD-10 Finland

Retained dental root

2.0

31.2

379

2005

S21

ICPC

Skin texture symptom/complaint

1.6

31.2

762

4944

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

31.1

1113

7882

F34.0

ICD-10 Finland

Cyclothymia

60.4

31.1

C08CA01

ATC

amlodipine; oral

1.4

31.1

1847

14434

M03BX01

ATC

baclofen; systemic

3.9

31.0

236

P19

ICPC

Drug abuse

8.4

30.8

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

30.8

375

1985

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

85.6

30.7

M02AA10

ATC

ketoprofen; topical

1.6

30.7

774

5060

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.9

30.5

148

526

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.8

30.3

153

555

P98

ICPC

Psychosis NOS/other

7.9

30.2

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

38.3

30.2

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.3

30.2

184

SPAT1312

SPAT

General health counselling

1.5

30.1

1410

10528

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

4.2

30.1

193

D06

ICPC

Abdominal pain localized other

1.8

29.9

439

2472

R5110, ,

SPAT

1.9

29.9

416

2303

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

29.8

399

2180

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

304.1

29.8

N06AA21

ATC

maprotiline; systemic

304.1

29.8

P17

ICPC

Tobacco abuse

4.2

29.8

190

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

28.8

29.8

XKC03

NOMESCO Finland

Water cystometry

2.8

29.7

148

534

Z73.0

ICD-10 Finland

Burn-out

2.7

29.6

159

596

J01CA08

ATC

pivmecillinam; oral

1.4

29.6

1906

15071

F06.7

ICD-10 Finland

Mild cognitive disorder

2.9

29.6

138

480

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

29.5

489

2854

A11

ICPC

Chest pain NOS

1.9

29.4

419

2336

F05.9

ICD-10 Finland

Delirium, unspecified

3.6

29.3

264

M01AH05

ATC

etoricoxib; oral

1.4

29.3

3128

26896

A03DA02

ATC

pitofenone and analgesics; systemic

3.4

29.3

107

322

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

29.2

584

3594

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

29.2

275

1326

SPAT1389

SPAT

Visit based on need for special support

4.6

29.1

148

C01CA01

ATC

etilefrine; systemic

6.6

28.9

U05

ICPC

Urination problems other

2.2

28.9

255

1199

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

28.0

28.8

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

8.5

28.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

28.7

189

783

F34.9

ICD-10 Finland

Persistent mood [affective] disorder, unspecified

33.9

28.7

J01FF01

ATC

clindamycin; systemic

1.5

28.6

1267

9344

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

28.5

2348

19313

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

28.5

256

1212

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

11.2

28.4

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

9.2

28.3

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

6.1

27.9

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.3

27.9

107

R55

ICD-10 Finland

Syncope and collapse

1.8

27.7

487

2891

ZXY03

NOMESCO Finland

Occupational therapist

42.7

27.7

EB1SA, ,

SPAT

2.1

27.7

259

1246

L16

ICPC

Ankle symptom/complaint

1.7

27.7

568

3519

F20

ICD-10 Finland

Schizophrenia

7.5

27.6

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

27.5

1017

7227

F20.0

ICD-10 Finland

Paranoid schizophrenia

7.3

27.5

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

27.4

1134

8243

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

25.5

27.4

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

27.4

472

2785

R51

ICD-10 Finland

Headache

2.1

27.4

254

1218

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

27.3

300

1532

M03AX01

ATC

botulinum toxin; parenteral

4.4

27.3

156

A10BJ02

ATC

liraglutide; parenteral

2.7

27.3

145

541

N05AX16

ATC

brexpiprazole; oral

53.6

27.2

D10AF01

ATC

clindamycin; topical

2.2

27.1

226

1038

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

27.1

491

2939

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

27.1

1140

8313

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.8

26.9

441

2565

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

3.1

26.9

110

355

SPAT1247

SPAT

Outpatient detoxication and monitoring

9.7

26.8

IEV99

NOMESCO Finland

Other psychiatric network intervention

24.8

26.5

N02CC03

ATC

zolmitriptan; nasal, oral

2.2

26.5

239

1133

R60.9

ICD-10 Finland

Oedema, unspecified

2.0

26.5

279

1403

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

26.4

2979

25633

ZXA00

NOMESCO Finland

Right side

1.5

26.4

1195

8830

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

26.3

814

5567

A08

ICPC

Swelling

2.0

26.3

282

1428

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

8.7

26.3

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

26.2

366

2026

Z01.7

ICD-10 Finland

Laboratory examination

1.5

26.2

821

5628

SPAT1058

SPAT

PEF monitoring instruction

1.9

26.2

363

2005

U01

ICPC

Dysuria/painful urination

1.9

26.1

370

2057

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

26.1

559

3498

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

36.9

26.1

2961A

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,TARKEMMIN MÄÄRITTELEMÄTÖN]

36.9

26.1

H01

ICPC

Ear pain/earache

1.7

26.0

530

3274

J01MA12

ATC

levofloxacin; systemic

1.5

25.9

823

5657

S04

ICPC

Lump/swelling localized

1.7

25.9

529

3271

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.8

25.9

133

488

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.7

25.7

136

506

C08DA01

ATC

verapamil; systemic

2.4

25.7

187

811

M03BB52

ATC

chlormezanone, combinations excl. psycholeptics; oral, rectal

3.0

25.6

113

381

3000A

ICD-9 Finland

Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]

21.9

25.6

RS220, ,

NOMESCO Finland

4.2

25.6

160

SPAT1284

SPAT

Extensive health certificate

3.0

25.6

111

371

X11

ICPC

Menopausal symptom/complaint

3.4

25.5

265

C07AB03

ATC

atenolol; systemic

2.1

25.5

255

1258

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

25.5

287

1479

D07AD01

ATC

clobetasol; topical

1.5

25.4

820

5654

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

7.3

25.4

K85

ICPC

Elevated blood pressure

1.5

25.4

817

5631

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.2

25.4

223

1047

IFA01, ,

SPAT

28.5

25.3

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

25.3

1479

11430

G01AF05

ATC

econazole; vaginal

1.8

25.1

366

2054

WX780

NOMESCO Finland

Remote monitoring CPAP

2.2

25.1

224

1058

M01AX01

ATC

nabumetone; oral

2.3

25.1

197

883

WZA10, ,

SPAT

6.6

25.1

A02BB01

ATC

misoprostol; oral

7.0

25.0

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

9.7

25.0

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

25.0

261

1309

N02BA71

ATC

acetylsalicylic acid, combinations with psycholeptics; systemic

3.0

24.9

113

387

WX002

NOMESCO Finland

Sedation and analgesia

1.5

24.9

863

6039

A05

ICPC

Feeling ill

2.1

24.8

235

1136

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

24.8

878

6174

N02BE51

ATC

paracetamol, combinations excl. psycholeptics; systemic

4.4

24.7

139

E03

ICD-10 Finland

Other hypothyroidism

2.0

24.7

292

1530

K03.00

ICD-10 Finland

Approximal wear

1.8

24.7

374

2124

R01AD12

ATC

fluticasone furoate; nasal

1.4

24.6

1442

11144

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

24.6

208

962

EB1AA, ,

SPAT

1.9

24.5

313

1683

D09

ICPC

Nausea

2.3

24.4

193

867

OAA80, ,

SPAT

0.4

24.4

137

3219

D01AC02

ATC

miconazole; topical

1.9

24.4

334

1837

SPAT1237

SPAT

Psychotherapy

9.4

24.4

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.9

24.4

339

1874

J02AC02

ATC

itraconazole; systemic

1.5

24.4

843

5896

R32

ICD-10 Finland

Unspecified urinary incontinence

2.7

24.3

129

481

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

24.3

156

639

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

24.3

565

3609

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

22.0

24.3

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

20.1

24.3

T42.4

ICD-10 Finland

Poisoning: Benzodiazepines

48.6

24.3

R03AK07

ATC

formoterol and budesonide; inhalant

1.5

24.2

986

7124

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

24.2

1146

8524

G03FB05

ATC

norethisterone and estrogen; systemic

1.7

24.1

518

3243

SPAT1051

SPAT

Guidance regarding sleep disorders

3.5

24.1

236

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.1

24.1

222

1062

N07BB04

ATC

naltrexone; oral

37.7

23.9

R03BC03

ATC

nedocromil; inhalant

1.9

23.9

317

1726

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

23.8

138

538

G50.1

ICD-10 Finland

Atypical facial pain

3.3

23.8

272

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.7

23.8

481

2964

SPAT1106

SPAT

Acupuncture

5.7

23.8

G04BD09

ATC

trospium; oral

2.9

23.8

109

376

S02

ICPC

Pruritus

2.4

23.7

167

714

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

6.1

23.7

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

23.7

2293

19155

G04BD01

ATC

emepronium; systemic

5.8

23.6

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

125.6

23.6

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

23.6

440

2653

R06AE09

ATC

levocetirizine; oral

1.6

23.5

646

4294

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.8

23.5

338

1889

9691A

ICD-9 Finland

Poisoning by psychotropic agents, Phenothiazine-based tranquillisers

23.7

23.4

M01AC01

ATC

piroxicam; systemic, rectal

1.6

23.4

595

3882

C09CA06

ATC

candesartan; oral

1.4

23.4

1155

8646

D02

ICPC

Abdominal pain epigastric

1.9

23.4

297

1594

N04BB01

ATC

amantadine; oral

3.4

23.3

241

WX722

NOMESCO Finland

PEEP

2.2

23.3

206

969

A13

ICPC

Concern/fear medical treatment

3.0

23.3

106

364

F60.1

ICD-10 Finland

Schizoid personality disorder

33.5

23.3

L05

ICPC

Flank/axilla symptom/complaint

1.9

23.3

308

1675

R00.2

ICD-10 Finland

Palpitations

1.8

23.3

367

2108

X23

ICPC

Fear sexually transm dis female

2.5

23.3

151

622

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.1

23.3

223

1083

C10AA05

ATC

atorvastatin; oral

1.3

23.2

2014

16531

N29

ICPC

Neurological sympt/complt other

3.2

23.1

282

ZXA05

NOMESCO Finland

Left side

1.4

23.1

1098

8161

T74.1

ICD-10 Finland

Physical abuse

3.7

23.1

200

C01DA14

ATC

isosorbide mononitrate; oral

1.6

23.0

599

3929

A10BH01

ATC

sitagliptin; oral

1.7

23.0

416

2485

V03AA02, ,

ATC

54.2

23.0

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

23.0

275

1446

SPAT1281

SPAT

Other administrative function

1.8

23.0

328

1827

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

23.0

461

2833

N02CC02

ATC

naratriptan; oral

3.2

22.9

284

K58

ICD-10 Finland

Irritable bowel syndrome

2.6

22.9

134

526

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.6

22.8

115

A03CA05

ATC

glycopyrronium bromide and psycholeptics; systemic

4.0

22.8

161

IEY03

NOMESCO Finland

Vocational rehabilitation

65.2

22.8

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

22.8

181

815

-50

ICPC

Medication/prescr/renewal

2.3

22.8

178

796

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.6

22.8

581

3794

IEY21

NOMESCO Finland

Other intensified psychiatric treatment

30.2

22.7

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

22.7

695

4729

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

22.7

1211

9183

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

22.7

609

4023

R03AC13

ATC

formoterol; inhalant

2.1

22.7

227

1120

N06AE02, ,

ATC

83.8

22.7

ICZ04

NOMESCO Finland

Preparation of psychiatric treatment plan

40.2

22.6

P50

ICPC

Psychological, Medication/prescr/renewal

9.4

22.6

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

22.5

358

2061

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.1

22.5

224

1103

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

4.1

22.5

154

F43.2

ICD-10 Finland

Adjustment disorders

3.4

22.5

242

K04

ICPC

Palpitations/awareness of heart

2.0

22.5

258

1338

K08.80

ICD-10 Finland

Toothache NOS

1.7

22.5

421

2541

R01AD11

ATC

triamcinolone; nasal

1.7

22.5

393

2327

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

22.4

824

5827

E000006, ,

ATC

1.8

22.3

316

1756

K04.08

ICD-10 Finland

Other specified pulpit

1.8

22.3

338

1918

M54.8

ICD-10 Finland

Other dorsalgia

2.1

22.3

211

1020

F03

ICD-10 Finland

Unspecified dementia

2.5

22.2

144

593

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

22.2

316

1759

IER03

NOMESCO Finland

Psychiatric disorder-specific group intervention

27.4

22.2

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

27.4

22.2

G72.8

ICD-10 Finland

Other specified myopathies

3.7

22.2

187

R15

ICD-10 Finland

Faecal incontinence

2.6

22.2

133

528

F50.8

ICD-10 Finland

Other eating disorders

24.0

22.1

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

5.9

22.1

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.8

22.1

326

1835

R03BA08

ATC

ciclesonide; inhalant

1.7

22.1

400

2391

ZXY61

NOMESCO Finland

2-person team, special workers

52.2

22.1

A91

ICPC

Abnormal result investigation NOS

1.9

22.1

264

1389

WX110, ,

SPAT

2.0

22.0

258

1347

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

22.0

552

3588

IEZ99

NOMESCO Finland

Other psychiatric rehabilitation intervention

35.2

22.0

G03FB06

ATC

medroxyprogesterone and estrogen; systemic

1.7

22.0

392

2334

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.0

21.9

318

F34.8

ICD-10 Finland

Other persistent mood [affective] disorders

62.8

21.8

H02AB04

ATC

methylprednisolone; systemic

1.5

21.8

641

4321

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

21.8

257

1345

SPAT1262

SPAT

Handing over of treatment supplies

1.5

21.8

730

5062

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

21.8

357

2074

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.1

21.8

211

1029

IAA02, ,

SPAT

17.1

21.7

Z00.0

ICD-10 Finland

General medical examination

1.5

21.7

844

6031

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

21.7

594

3940

R5599

NOMESCO Finland

Other rehabilitation service

2.6

21.7

129

510

F25.1

ICD-10 Finland

Schizoaffective disorder, depressive type

38.8

21.7

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

21.7

825

5871

L14

ICPC

Leg/thigh symptom/complaint

1.7

21.7

378

2236

G03FB08

ATC

dydrogesterone and estrogen; systemic

1.9

21.7

287

1562

OAB72, ,

SPAT

3.3

21.6

248

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

21.6

2259

18996

H02BX01

ATC

methylprednisolone, combinations; systemic

2.1

21.6

221

1100

R04

ICPC

Breathing problem other

2.2

21.6

185

860

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.7

21.6

120

459

WX290, ,

SPAT

2.4

21.6

155

669

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

21.5

196

933

K07

ICPC

Swollen ankles/oedema

2.0

21.5

224

1122

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.0

21.4

151

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

8.3

21.4

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

8.3

21.4

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

21.4

4622

43292

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

5.9

21.3

L04

ICPC

Chest symptom/complaint

1.8

21.3

300

1665

F60.0

ICD-10 Finland

Paranoid personality disorder

23.2

21.2

IEY19, ,

SPAT

20.8

21.2

X14

ICPC

Vaginal discharge

3.0

21.1

319

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

3.7

21.1

175

SPAT1263

SPAT

Sampling

1.3

21.1

1820

14874

WZC00, ,

SPAT

1.5

21.0

688

4747

SAA04

NOMESCO Finland

Special examination of mouth

2.0

20.9

232

1190

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.1

20.9

190

905

T07

ICPC

Weight gain

3.3

20.8

244

N06BA07

ATC

modafinil; oral

17.9

20.8

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.9

20.8

338

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

20.8

446

2789

OAB40, ,

SPAT

7.4

20.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

20.7

197

954

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

20.7

175

809

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

20.6

355

2091

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.6

20.6

124

493

IDR03

NOMESCO Finland

Systematic group therapy, dialectical behaviour therapy (DBT)

110.5

20.6

W19

ICD-10 Finland

Unspecified fall

1.7

20.6

419

2585

ZYY01

NOMESCO Finland

Contact between professionals

15.8

20.5

SCA02

NOMESCO Finland

Preventive oral health care

1.7

20.5

415

2556

S10

ICPC

Boil/carbuncle

1.9

20.5

264

1424

Z03

ICPC

Housing/neighbourhood problem

6.5

20.4

N76.0

ICD-10 Finland

Acute vaginitis

1.9

20.3

244

1285

IAB11

NOMESCO Finland

Psychiatric mood consultation

22.4

20.3

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

22.4

20.3

U13

ICPC

Bladder symptom/complaint other

2.4

20.3

135

563

R03AC12

ATC

salmeterol; inhalant

2.1

20.3

188

902

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

20.2

120

475

ZXY80

NOMESCO Finland

Doctor in multidisciplinary team

32.6

20.2

I95.1

ICD-10 Finland

Orthostatic hypotension

2.3

20.1

150

658

ZXD35

NOMESCO Finland

Usual procedure

2.4

20.1

144

621

N02CC04

ATC

rizatriptan; oral

2.0

20.1

227

1171

R13

ICD-10 Finland

Dysphagia

1.8

20.1

300

1696

D07AC13

ATC

mometasone; topical

1.4

20.0

1304

10190

R4110, ,

SPAT

1.5

20.0

636

4357

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.3

20.0

151

666

R30.0

ICD-10 Finland

Dysuria

2.1

20.0

197

967

N05AA03

ATC

promazine; systemic

27.1

20.0

IEY06

NOMESCO Finland

Psychiatric treatment and rehabilitation coaching

27.1

20.0

N30

ICD-10 Finland

Cystitis

1.7

20.0

360

2148

G04BD11

ATC

fesoterodine; oral

2.6

20.0

120

477

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

20.0

799

5736

-60

ICPC

Result test/procedure

1.9

19.9

256

1379

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

19.9

146

636

A10BK03

ATC

empagliflozin; oral

1.6

19.9

475

3049

UJH02

NOMESCO Finland

Anoscopy

2.1

19.9

187

902

2961B

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,LIEVÄASTEINEN]

57.7

19.9

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.0

19.9

203

1010

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

19.9

1156

8870

D82

ICPC

Teeth/gum disease

1.3

19.9

1721

14041

N39.3

ICD-10 Finland

Stress incontinence

1.7

19.8

341

2008

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3028707) Methadone [Presence] in Urine by Screen method

291

211

14.52

318.19

3.1

2.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

159

28.22

235.65

12.2

18.3

0.61

0.66

mmol/l

0.76

139

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1097

4322

2.93

196.19

2.1

1.5

1.51

1.41

5.47

952

3819

(3011288) Drugs identified in Urine by Screen method Nominal

347

596

6.15

194.11

4.1

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

230

292

8.18

169.84

6.1

5.3

368.18

360.45

umol/l

0.27

199

262

(44816559) Phosphatidylethanol [Mass/volume] in Blood

501

1320

4.08

168.56

1.8

1.5

0.25

0.28

mg/l

0.62

240

608

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2954

19334

2.17

164.08

2.4

2.0

97.98

96.66

pmol/l

0.79

1539

10088

(3019309) Folate [Moles/volume] in Red Blood Cells

1314

6353

2.41

151.14

1.9

1.7

1198.12

1160.49

nmol/l

0.67

982

4851

(3015377) Calcium [Moles/volume] in Serum or Plasma

2447

15314

2.10

147.74

3.4

3.8

2.36

mmol/l

0.07

2211

13900

(3021960) Folate [Moles/volume] in Serum or Plasma

2032

12050

2.10

139.68

1.8

1.6

20.92

20.20

nmol/l

1.34

1751

10137

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2936

20059

2.02

134.88

6.8

6.7

1.21

mmol/l

0.00

2730

18612

(1001926) Buprenorphine [Presence] in Urine by Screen method

344

811

4.46

133.46

3.0

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4385

34916

2.38

132.42

5.7

4.2

14.56

14.86

pmol/l

13.83

4051

32195

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

102

18.22

127.03

1.6

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3170

22543

1.99

126.47

7.0

7.4

1.21

mmol/l

0.10

2743

19512

(3024561) Albumin [Mass/volume] in Serum or Plasma

2913

20126

1.97

126.39

4.7

5.3

36.17

35.74

g/l

4.11

2721

18923

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2945

20558

1.95

122.44

3.7

3.0

102.39

132.67

ug/l

17.89

2735

19349

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1537

8660

2.08

117.09

2.9

3.2

2.45

mmol/l

0.85

1347

7804

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1818

10927

2.00

115.49

2.7

2.3

2.68

2.81

mg/l

1.75

1572

9538

(3018418) pH of Serum or Plasma

2115

13441

1.94

113.80

4.3

4.5

7.40

0.51

1469

9594

(3016879) Cocaine [Presence] in Urine

367

1023

3.78

113.08

3.0

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2910

20678

1.89

109.82

2.8

2.4

78.18

78.32

nmol/l

0.09

2653

18837

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4317

35190

2.14

106.43

9.1

8.4

78.78

78.67

u/l

0.05

4102

33548

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2099

13692

1.87

101.15

2.5

2.1

207.59

202.84

u/l

0.09

1964

12943

(3000764) Benzodiazepines [Presence] in Urine

373

1139

3.44

99.95

3.1

1.4

—

(3028300) Cannabinoids [Presence] in Urine

375

1154

3.42

99.26

3.1

1.4

—

(3027008) Opiates [Presence] in Urine

373

1152

3.40

98.15

3.1

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3189

23883

1.82

96.01

6.6

6.8

10.39

11.62

umol/l

7.81

3027

22871

(3036481) Cortisol [Moles/volume] in Serum or Plasma

802

3785

2.31

93.21

2.3

2.5

360.38

385.38

nmol/l

3.24

743

3553

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1624

9984

1.90

92.31

1.4

1.3

1.26

1.74

u/ml

1.23

428

2759

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2223

15133

1.80

90.41

3.6

3.3

37.61

34.80

u/l

0.16

2079

14331

(3013650) Neutrophils [#/volume] in Blood by Automated count

3390

26166

1.80

89.00

11.1

9.8

4.13

4.05

e9/l

1.13

2877

22623

(3027944) Amphetamines [Presence] in Urine

357

1149

3.26

87.72

2.9

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3673

29165

1.82

86.21

5.8

4.2

2349.05

1402.26

e6/l

0.17

380

(3030467) Casts [#/volume] in Urine by Automated count

1897

12503

1.80

84.58

3.8

3.1

0.38

0.39

e6/l

0.07

1381

9072

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4099

33845

1.88

82.57

4.8

4.4

12.16

12.15

mm/h

0.01

3863

31830

(3018095) Leukocytes [#/volume] in Urine

2373

16768

1.74

82.50

4.6

3.8

82.61

96.33

e6/l

0.21

1655

11711

(36304419) Bacteria [Presence] in Urine

1815

11891

1.79

82.00

3.7

3.1

190.38

289.74

estimate

—

(3048689) Calprotectin [Mass/mass] in Stool

1011

5509

2.03

80.42

2.4

2.5

111.94

141.57

ug/g

2.02

793

4463

(3019198) Lymphocytes [#/volume] in Blood

3105

23777

1.72

79.50

7.0

6.4

1.93

1.90

e9/l

0.31

2673

20883

(3006315) Basophils [#/volume] in Blood

3052

23326

1.71

78.07

6.9

6.4

0.04

e9/l

0.29

2537

19976

(3001604) Monocytes [#/volume] in Blood

3044

23254

1.71

77.95

6.9

6.4

0.58

e9/l

1.00

2531

19924

(3002582) Erythrocytes [#/volume] in Urine

2106

14580

1.73

77.32

3.9

3.2

33.75

76.28

e6/l

2.47

1595

11032

(3013115) Eosinophils [#/volume] in Blood

3123

24058

1.71

77.21

7.4

6.5

0.19

e9/l

0.37

2671

20976

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4789

42074

2.25

76.32

7.4

5.0

1.79

1.93

mu/l

16.98

4516

38954

(3007164) IgA [Mass/volume] in Serum or Plasma

1419

8818

1.83

75.22

1.5

2.41

2.44

g/l

0.17

814

5576

(3015736) pH of Urine

2581

19025

1.69

74.09

3.9

3.3

6.25

6.20

1.74

1334

10645

(3033658) Prothrombin time (PT) actual/Normal

1750

11743

1.73

70.29

4.7

4.1

91.93

90.05

2.44

1712

11516

(3013826) Glucose [Moles/volume] in Serum or Plasma

3346

26649

1.68

69.28

5.6

4.8

6.63

6.68

mmol/l

0.88

3179

25244

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1387

8743

1.79

69.17

1.9

1.7

46085863.72

36933331.73

pmol/l

0.18

1124

7362

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1999

13959

1.69

68.97

2.8

2.6

57.96

66.37

u/l

0.79

1838

13038

(3044889) 12 lead EKG panel

3886

32265

1.73

68.29

4.8

3.9

0.58

4642.51

0.49

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

21.05

63.75

2.4

3.0

16.95

18.54

umol/l

0.26

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

791

4267

2.00

63.44

2.7

2.4

45.36

39.52

u/l

0.43

663

3637

(3009508) Creatinine [Moles/volume] in Urine

2192

15943

1.63

62.87

3.8

3.4

7.46

mmol/l

0.00

1847

13560

(3000850) Epithelial cells [#/volume] in Urine

1493

9855

1.71

62.16

3.0

2.7

5.47

5.42

e6/l

0.05

1356

9012

(4198724) Urine methamphetamine measurement

10.12

61.96

3.2

1.5

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3724

30912

1.66

61.69

4.3

3.0

53.49

46.02

u/l

3.78

3475

29147

(3006504) Eosinophils/Leukocytes in Blood

2761

21416

1.59

59.44

6.8

6.6

2.86

2.85

0.09

2573

20137

(3019069) Monocytes/Leukocytes in Blood

2765

21467

1.59

59.19

6.9

6.7

8.77

8.91

1.98

2573

20201

(3022096) Basophils/Leukocytes in Blood

2756

21436

1.59

58.12

6.9

6.7

0.71

0.69

1.13

2561

20139

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

639

3300

2.06

57.49

2.2

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1180

7478

1.74

56.03

2.9

3.5

0.82

mmol/l

0.24

1093

7080

(3002030) Lymphocytes/Leukocytes in Blood

2804

22010

1.57

55.97

6.9

6.6

27.97

27.86

0.23

2640

20904

(3021589) Normoblasts [#/volume] in Blood

2644

20524

1.57

55.08

12.4

11.2

0.00

e9/l

0.07

2061

16748

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

678

3641

1.99

54.54

2.3

1.9

—

(40758558) Short blood count panel - Blood

1932

13993

1.59

54.11

7.6

6.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1581

10909

1.64

54.09

4.3

3.6

0.00

0.17

—

119

(3021601) Nitrite [Presence] in Urine by Test strip

3000

24045

1.56

53.60

4.5

3.7

0.00

estimate

0.80

611

4883

(3018010) Neutrophils/Leukocytes in Blood

2748

21606

1.56

53.44

6.7

6.5

57.08

57.23

0.27

2608

20709

(40768797) Stomach Pathology biopsy report

1009

6197

1.77

53.14

1.3

1.2

—

(3009261) Glucose [Presence] in Urine by Test strip

3041

24536

1.55

52.03

4.5

3.7

0.01

0.23

estimate

0.52

584

4714

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

546

2758

2.09

51.89

3.0

3.7

4.37

4.51

pmol/l

2.78

472

2512

(3035350) Ketones [Presence] in Urine by Test strip

3019

24337

1.55

51.72

4.5

3.7

10.89

3.86

estimate

0.80

621

5032

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1094

6937

1.72

51.27

2.4

2.7

2.37

2.31

g/l

2.86

983

6486

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1212

7903

1.69

51.22

3.3

2.8

1.08

1.09

e6/l

0.03

611

4179

(3026782) Osmolality of Urine

1255

8307

1.67

49.90

3.1

2.9

508.09

535.33

mosm/kgh2o

4.36

1089

7324

(3014111) Lactate [Moles/volume] in Serum or Plasma

694

3880

1.91

49.27

7.8

8.0

1.30

1.29

mmol/l

0.11

678

3819

(3022948) Iron [Moles/volume] in Serum or Plasma

1148

7454

1.69

49.01

2.5

2.7

12.83

13.03

umol/l

0.43

1062

7021

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1112

7212

1.68

47.49

3.5

3.0

3.38

2.65

e6/l

1.04

506

3475

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

8.44

47.14

2.3

2.8

126.33

139.59

nmol/l

0.41

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1807

13306

1.54

44.93

3.3

3.1

943.01

1334.69

ng/l

5.11

1514

11585

(3017446) Testosterone [Moles/volume] in Serum or Plasma

616

3440

1.89

43.59

2.9

2.1

13.16

13.41

nmol/l

0.32

549

3142

(3000991) Gas panel - Venous blood

659

3767

1.85

43.34

8.8

9.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

997

6429

1.68

43.03

2.5

2.7

21.63

22.77

2.04

916

6042

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

852

5288

1.73

42.31

2.6

2.8

7.41

8.82

umol/l

1.22

721

4705

(3021387) Prolactin [Units/volume] in Serum or Plasma

275

1133

2.50

42.26

1.9

1.8

338.10

285.26

mu/l

2.13

250

1050

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

597

3357

1.88

41.24

1.6

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

333

1511

2.28

41.21

1.6

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

253

1033

2.52

39.62

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

1618

11891

1.52

39.43

4.7

4.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

905

5810

1.67

39.38

4.7

6.5

1.03

1.04

mmol/l

0.54

832

5443

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1388

9892

1.54

38.94

1.9

1.7

1.02

1.26

mg/l

3.12

1067

7778

(3014765) Yersinia sp identified in Stool by Organism specific culture

252

1039

2.50

38.65

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

252

1047

2.48

38.02

1.2

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4994

46585

1.99

37.80

23.8

17.0

139.55

139.79

mmol/l

9.26

4922

45686

(3022145) Colonoscopy Study observation

845

5390

1.67

37.53

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

537

3013

1.87

37.19

1.5

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

277

1214

2.35

37.13

2.1

1.8

41.62

42.60

nmol/l

0.22

272

1184

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4892

45428

1.84

36.09

19.6

14.6

23.06

24.27

mg/l

1.71

4121

36933

(3032080) INR in Blood by Coagulation assay

2559

20834

1.44

35.83

14.3

14.5

1.23

1.25

inr

0.86

2096

17333

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

778

4914

1.68

35.74

2.0

1.8

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

107

5.95

35.51

2.8

2.3

128.41

148.81

umol/l

0.15

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1214

8557

1.54

35.26

1.4

1.3

60.81

34.37

iu/ml

0.38

304

2721

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2143

16932

1.44

35.09

4.3

3.4

29.87

44.48

ng/l

2.77

1464

11595

(3023103) Potassium [Moles/volume] in Serum or Plasma

4992

46716

1.94

35.05

23.8

17.3

3.96

3.97

mmol/l

2.50

4912

45715

(3019150) Specific gravity of Urine by Refractometry

1417

10352

1.50

34.66

4.7

3.8

1.02

kg/l

0.48

906

6841

(3000570) Elastase.pancreatic [Mass/mass] in Stool

275

1238

2.29

34.62

1.4

289.40

268.02

ug/g

0.36

162

739

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

221

904

2.51

34.47

2.1

1.8

205.99

208.65

pmol/l

0.13

207

868

(1002224) Polysomnography panel

396

2063

1.99

34.15

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

812

5251

1.64

33.91

2.0

1.7

—

(3012516) Albumin [Mass/volume] in Urine

1956

15287

1.44

33.54

3.7

3.5

40.29

45.67

mg/l

0.58

1261

9608

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1222

8706

1.52

33.53

4.2

3.7

174.56

599.39

ng/l

3.25

928

6784

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1029

7079

1.56

33.07

2.0

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

588

3513

1.76

32.91

3.6

3.1

4.54

kpa

0.01

574

3426

(36660697) Celiac disease serology panel - Serum

575

3418

1.76

32.75

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

677

4238

1.68

31.93

2.3

0.21

g/l

1.17

625

4000

(3037522) Nuclear Ab [Titer] in Serum

943

6425

1.57

31.46

1.4

455.20

556.77

titre

1.04

179

1448

(3021447) Carbon dioxide [Partial pressure] in Venous blood

679

4277

1.67

31.24

3.8

3.7

5.92

5.78

kpa

2.96

668

4180

(3014576) Chloride [Moles/volume] in Serum or Plasma

911

6172

1.57

31.12

8.2

7.4

104.11

104.44

mmol/l

1.24

911

6167

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4704

43544

1.64

30.76

7.8

6.0

39.27

39.11

mmol/mol

0.62

4429

40896

(3018677) aPTT in Platelet poor plasma by Coagulation assay

997

6913

1.54

30.67

2.0

2.1

29.45

29.68

0.64

976

6745

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4770

44320

1.67

30.60

6.3

4.9

6.03

5.90

mmol/l

8.79

4438

40956

(3019977) pH of Arterial blood

778

5106

1.61

30.34

7.9

8.0

7.42

0.05

388

2706

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

777

5105

1.61

30.15

7.9

8.0

5.23

5.08

kpa

4.75

755

4909

(3020682) Albumin/Creatinine [Ratio] in Urine

1958

15521

1.41

30.12

4.4

4.2

7.79

8.32

mg/mmol

0.19

1195

9556

(3002032) Base excess in Venous blood by calculation

661

4172

1.67

30.11

3.8

3.7

1.99

1.75

mmol/l

0.96

611

3663

(3003396) Base excess in Arterial blood by calculation

772

5068

1.61

30.05

7.9

1.10

0.87

mmol/l

0.89

686

4165

(3027801) Oxygen [Partial pressure] in Arterial blood

776

5102

1.61

30.02

7.9

8.0

11.58

12.79

kpa

10.82

752

4905

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1117

7981

1.50

29.74

1.3

7.12

12.97

u/ml

3.12

400

3209

(3025941) Bacteria identified in Stool by Culture

399

2185

1.89

29.61

1.3

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

753

4991

1.59

28.02

2.2

2.6

1.83

1.80

0.38

662

4499

(46235355) HIV 1 and 2 tests - Meaningful Use set

1008

7173

1.50

27.07

2.1

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

223

1027

2.22

26.58

1.4

1.3

8.72

11.61

u/l

2.65

170

845

(3012544) pH of Venous blood

669

4373

1.61

26.29

3.9

3.7

7.38

0.28

329

2500

(3017143) Hepatitis C virus Ab [Presence] in Serum

732

4908

1.57

25.77

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

381

2150

1.83

25.66

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

364

2034

1.85

25.30

2.6

1.9

—

(3016502) Oxygen saturation in Arterial blood

684

4536

1.58

25.23

8.3

8.4

94.76

95.80

2.84

672

4366

(3000494) Fungus identified in Specimen by Culture

817

5639

1.53

25.20

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1661

13102

1.39

25.16

5.1

3.9

0.00

estimate

2.41

585

4518

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

360

3.04

25.00

1.6

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

737

4984

1.55

24.93

1.9

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

310

1663

1.92

24.45

2.5

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

480

2943

1.69

24.20

10.3

10.0

92.88

94.20

3.03

480

2933

(3023183) Ammonium ion [Moles/volume] in Plasma

180

792

2.32

23.94

2.5

2.8

38.27

34.29

umol/l

0.36

161

725

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

464

2830

1.70

23.84

10.4

10.2

0.63

0.10

464

2805

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4741

44457

1.56

23.76

19.5

14.6

81.81

80.64

ml/min/173m2

3.97

4473

41063

(3023323) Follitropin [Units/volume] in Serum or Plasma

351

1980

1.83

23.65

1.5

1.3

24.99

32.09

iu/l

3.94

290

1723

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

106

362

2.97

23.54

1.4

1.9

337.02

350.74

mu/l

0.19

289

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2417

20374

1.34

23.36

2.0

1.9

1.46

1.32

mmol/l

10.42

1995

17162

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

474

2932

1.68

23.08

10.3

9.9

1.34

1.26

1.23

474

2908

(3052851) Hemolysis interference index of Serum or Plasma

238

1190

2.05

22.97

2.6

3.2

1.42

2.45

index

1.21

124

623

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

22.93

1.5

0.0

453.91

—

nmol/l

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

642

4288

1.56

22.83

8.7

8.9

121.31

121.15

g/l

0.07

636

4185

(3042936) Bacteria identified in Isolate by Culture

891

6389

1.47

22.62

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

547

3533

1.61

22.42

2.5

2.2

5.48

8.25

ug/l

4.55

464

3185

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

381

2244

1.75

22.17

3.8

2.8

0.60

0.61

0.43

381

2233

(3026493) Urate [Moles/volume] in Serum or Plasma

1561

12388

1.37

22.16

2.6

2.8

340.45

341.21

umol/l

0.11

1322

11060

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

205

984

2.13

22.06

1.2

1.3

439.82

569.81

mg/l

6.32

198

950

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3159

27810

1.33

22.03

3.1

2.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

499

3167

1.63

21.95

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

162

712

2.31

21.63

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

162

712

2.31

21.63

1.4

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

721

5003

1.51

21.44

8.2

6.2

—

(3024928) Oxygen saturation in Venous blood

220

1104

2.04

21.03

3.4

3.1

60.56

62.47

0.59

211

1086

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

430

2663

1.67

20.80

3.7

3.6

5.21

5.11

kpa

1.72

410

2553

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

417

2566

1.68

20.67

1.8

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

577

3848

1.56

20.56

2.3

2.7

73.24

68.95

e9/l

1.54

411

2840

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

180

849

2.16

20.27

1.2

1.4

12.23

33.09

e6/l

1.22

128

632

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

367

2202

1.72

19.97

3.4

1.86

mmol/l

0.00

274

1618

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2164

18235

1.31

19.84

4.5

3.6

0.22

0.29

estimate

0.09

510

3991

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

263

1432

1.88

19.83

1.4

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1303

10205

1.37

19.69

5.0

4.7

—

(3003181) Sodium [Moles/volume] in Urine

160

729

2.23

19.65

1.5

1.3

56.81

62.62

mmol/l

1.05

126

597

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

269

1480

1.86

19.63

1.9

2.3

548.04

670.12

ug/l

0.27

254

1403

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

426

2674

1.64

19.53

9.6

9.9

24.48

24.26

mmol/l

0.68

411

2639

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4143

38233

1.36

19.41

24.9

18.1

13.68

13.60

3.50

4087

37720

(3044640) Blood type and Crossmatch panel - Blood

1816

14967

1.32

19.41

2.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

180

867

2.11

19.23

1.2

1.4

912.01

867.07

e6/l

0.02

135

689

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1424

11349

1.35

19.11

2.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

207

3.36

19.09

1.0

316.32

355.42

ng/l

0.45

157

(3009343) pH of Capillary blood

411

2573

1.65

19.04

3.7

3.6

7.41

7.42

1.40

348

2105

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

210

3.32

18.66

1.0

36.74

44.71

ng/l

0.75

157

(40768804) Tissue Pathology biopsy report

2260

19273

1.30

18.54

2.2

2.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

208

3.30

18.25

1.0

801.34

724.87

ng/l

0.55

158

(3015171) Extractable nuclear Ab [Units/volume] in Serum

297

1725

1.76

18.13

1.3

0.19

1.22

u/ml

2.81

160

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

177

870

2.07

17.94

1.1

1.3

3.73

3.75

mmol/l

0.07

170

825

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

457

2983

1.58

17.81

1.2

100.62

146.31

u/ml

1.93

133

1152

(3023410) Appearance of Cerebral spinal fluid

101

393

2.60

17.62

1.3

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

520

3510

1.53

17.45

3.5

4.1

84.29

93.40

ng/l

1.73

440

3034

(3005322) IgE [Units/volume] in Serum or Plasma

435

2829

1.58

17.21

1.4

1.3

183.91

227.27

u/ml

0.72

396

2641

(3016018) Differential panel - Cerebral spinal fluid

112

467

2.43

16.91

1.2

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

476

3192

1.54

16.44

2.4

18.86

22.63

au/ml

0.34

376

(3004716) Salmonella sp identified in Stool by Organism specific culture

322

1967

1.68

16.39

1.2

1.4

—

(1616796) Gas panel - Central venous blood

177

909

1.98

15.93

4.6

3.8

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

218

1202

1.85

15.84

2.1

2.5

0.00

g/l

-0.00

200

1139

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

229

1283

1.82

15.80

2.1

2.5

0.00

g/l

-0.00

200

1142

(3020779) Urea [Moles/volume] in Serum or Plasma

576

4053

1.47

15.75

6.2

8.1

8.82

10.01

mmol/l

4.25

549

3899

(3014051) Protein [Presence] in Urine by Test strip

1597

13240

1.29

15.51

3.0

2.8

0.06

0.05

0.06

305

(3005719) IgG [Mass/volume] in Serum or Plasma

515

3563

1.49

15.32

2.5

3.0

10.61

10.71

g/l

0.20

461

3309

(3015235) Bicarbonate [Moles/volume] in Capillary blood

249

1452

1.75

15.02

2.9

3.0

25.03

24.74

mmol/l

0.59

243

1434

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

234

1348

1.77

14.73

2.0

2.5

0.00

0.02

g/l

1.10

209

1228

(3008295) Osmolality of Serum or Plasma

414

2.39

14.44

1.5

1.3

280.16

278.03

mosm/kgh2o

0.37

324

(3020191) Ethanol [Moles/volume] in Serum or Plasma

247

2.82

14.22

1.5

1.3

1.50

1.04

promille

1.62

205

(3020961) Endomysium IgA Ab [Titer] in Serum

317

2013

1.61

13.85

1.1

122.50

208.83

titre

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

432

2943

1.51

13.82

1.3

47.34

57.30

au/ml

0.47

228

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

321

2047

1.60

13.79

1.6

1.4

—

(3013512) EKG study

1878

16074

1.26

13.65

3.6

3.5

0.86

0.80

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

491

3445

1.47

13.58

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

609

4471

1.41

13.15

4.0

3.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

496

3513

1.45

13.05

4.2

3.9

1.23

mmol/l

0.17

416

3089

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

191

1079

1.80

12.88

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

985

7818

1.32

12.87

1.6

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

533

3841

1.43

12.77

2.1

2.9

66.69

66.46

g/l

0.28

479

3541

(3043409) Potassium [Moles/volume] in Arterial blood

195

1116

1.78

12.60

5.9

4.2

3.84

3.90

mmol/l

1.08

195

1099

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

260

1610

1.65

12.59

2.1

2.5

0.65

0.95

g/l

0.63

225

1396

(21494755) Public health laboratory ask at order entry panel

307

4631

0.64

12.58

1.3

1.4

—

(3011985) Renin [Units/volume] in Plasma

136

694

1.98

12.55

1.5

1.4

61.12

59.36

mu/l

0.03

119

626

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

824

6397

1.34

12.53

1.6

—

(3021901) Oxygen saturation in Capillary blood

156

839

1.88

12.33

3.7

3.0

90.21

90.36

0.12

149

815

(3028626) Oxygen [Partial pressure] in Capillary blood

172

958

1.82

12.17

3.6

3.0

8.04

8.20

kpa

0.75

166

937

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

337

2245

1.53

11.98

2.2

2.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

219

1320

1.69

11.78

1.3

89.00

153.08

titre

0.72

120

(3028026) IgM [Mass/volume] in Serum or Plasma

400

2785

1.47

11.49

1.8

1.9

1.11

1.35

g/l

3.54

360

2572

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

116

581

2.02

11.32

1.4

1.3

24.04

32.39

u/l

1.83

473

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

267

2.53

11.28

1.7

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

136

721

1.91

11.26

1.9

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5047

48965

1.49

11.22

26.1

19.2

76.64

76.79

umol/l

0.13

5013

48401

(40761536) Microorganisms panel - Urine sediment

475

3435

1.42

11.14

4.9

3.8

—

(3006653) Thiamine [Moles/volume] in Blood

178

2.88

11.09

1.2

140.51

132.81

nmol/l

0.69

178

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2434

21756

1.22

11.03

2.8

2.7

—

estimate

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5017

48633

1.46

11.03

15.2

11.7

26.71

26.10

u/l

1.66

4894

47285

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

215

1313

1.66

11.03

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

177

1026

1.75

10.99

1.3

27.24

50.68

u/ml

1.30

111

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

115

585

1.99

10.76

1.4

0.37

nmol/l

0.02

445

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

689

5328

1.34

10.66

4.2

5.0

236.04

244.66

u/l

0.82

654

5092

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

124

652

1.92

10.55

1.4

1.3

409.57

297.60

pmol/l

1.07

101

555

(3023420) DNA double strand Ab [Units/volume] in Serum

295

1968

1.53

10.44

1.6

1.8

6.16

6.67

iu/ml

0.10

450

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

226

1418

1.62

10.43

1.3

7.85

49.29

u/ml

5.14

(3008152) Bicarbonate [Moles/volume] in Arterial blood

376

2644

1.45

10.27

7.8

6.9

25.26

24.38

mmol/l

5.46

371

2511

(3049717) Cytology report of Urine Cyto stain

245

1577

1.58

10.18

2.5

2.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

267

1758

1.55

10.04

2.1

2.5

2.86

2.89

g/l

0.25

244

1607

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

245

1589

1.57

9.86

2.1

2.5

10.30

10.27

g/l

0.04

221

1422

(3006184) Hemoglobin [Mass/volume] in Capillary blood

170

1018

1.69

9.44

2.8

2.2

130.74

129.19

g/l

0.40

126

770

(1761868) Lipid panel - Serum or Plasma

1674

19046

0.82

9.44

3.4

3.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

113

3.20

9.43

1.2

76.72

110.54

nmol/l

1.37

(3023511) Choriogonadotropin [Units/volume] in Urine

495

2.00

9.41

1.4

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

232

1503

1.57

9.40

1.8

1.7

3.68

4.51

mg/l

0.54

191

1049

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

440

2.04

9.08

1.3

1.2

—

30.17

—

(3025130) Human papilloma virus identified in Specimen

119

650

1.85

9.07

1.6

1.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

122

3.05

8.95

2.0

3.1

26.46

29.53

umol/l

0.74

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4567

43855

1.27

8.94

4.8

4.2

1.40

1.26

mmol/l

29.08

4173

40609

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

251

1674

1.52

8.94

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

364

2.13

8.85

1.2

67.50

189.00

titre

1.90

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

268

2.33

8.84

1.1

1.17

14.19

nmol/l

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

497

3768

1.35

8.74

2.8

2.6

66.93

66.60

ml/min/173m2

0.06

230

1561

(3022313) Gas panel - Capillary blood

266

1805

1.50

8.73

3.5

3.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

193

1221

1.60

8.67

1.2

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1870

1.48

8.56

2.1

2.5

7.32

7.38

g/l

0.30

251

1718

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

1870

1.48

8.56

2.1

2.5

4.25

4.21

g/l

0.38

251

1719

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

211

1370

1.56

8.50

3.6

3.7

24.94

24.85

mmol/l

0.17

195

1251

(3002256) Pathology report gross observation

803

6537

1.27

8.35

1.3

—

(3045414) Leukocytes [Presence] in Urine

571

4448

1.32

8.34

2.2

2.1

0.03

0.02

estimate

0.13

118

952

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

271

1869

1.47

8.22

2.1

2.5

3.97

3.69

g/l

1.56

249

1717

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4833

46834

1.31

8.19

6.8

5.7

2.64

2.76

mmol/l

17.73

4510

43866

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

249

1693

1.49

8.11

1.6

16.83

18.18

u/ml

0.10

427

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

895

7409

1.25

8.04

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

420

5508

0.74

7.77

1.9

2.0

3.35

3.47

ratio

1.02

317

4265

(3026389) Candida sp identified in Specimen by Organism specific culture

106

589

1.82

7.71

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

203

1337

1.54

7.70

1.3

11.84

5.07

u/ml

0.29

128

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

282

1986

1.44

7.69

2.2

2.0

39.60

39.96

u/l

0.11

246

1766

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

117

2.92

7.68

1.1

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

179

1147

1.58

7.67

1.6

13612.28

11478.26

e6/l

0.25

118

799

(3016650) Hepatitis A virus Ab [Presence] in Serum

123

716

1.73

7.65

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

4.51

7.64

1.2

1.1

87.11

86.40

titre

0.01

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

123

718

1.73

7.58

1.4

1.3

0.14

0.28

nmol/l

—

(3016038) Potassium [Moles/volume] in Urine

262

2.23

7.52

1.1

31.13

35.32

mmol/l

0.82

233

(3007463) Buprenorphine [Presence] in Urine

+∞

7.29

17.3

0.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

201

1341

1.52

7.21

1.3

5.03

6.16

u/ml

0.23

195

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

354

2625

1.37

7.19

9.1

10.6

16.08

16.00

0.21

349

2524

(3012501) Base excess in Blood by calculation

138

845

1.65

7.14

4.8

3.8

2.96

2.48

mmol/l

0.76

584

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.05

7.07

2.1

2.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

853

0.41

6.98

1.5

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

172

1120

1.55

6.91

1.3

2.35

3.32

u/ml

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.97

6.88

2.1

1.9

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

117

696

1.70

6.78

1.4

1.3

0.64

4.75

nmol/l

0.77

112

676

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

411

1.91

6.75

1.3

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

105

609

1.74

6.67

1.4

1.3

0.16

0.21

nmol/l

0.83

490

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

104

602

1.74

6.65

1.1

3.36

3.56

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

6.42

6.62

1.1

—

mmol/l

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

6.42

6.62

1.1

1.0

—

mmol/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.34

6.54

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

209

2.26

6.38

1.3

1.2

176.26

162.09

mmol/24h

0.30

209

(3024891) Influenza virus A+B Ag [Presence] in Specimen

167

1103

1.53

6.32

1.2

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1473

13065

1.18

6.27

3.7

3.2

0.54

0.05

estimate

0.50

516

3826

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

7.01

6.21

1.0

1.5

—

37.86

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

138

2.55

6.18

1.2

1.4

861.94

114.83

nmol/24h

0.46

138

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.29

6.12

1.3

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4759

46270

1.25

6.12

5.8

5.0

4.56

4.71

mmol/l

19.68

4439

43492

(4094501) Cardiovascular stress test using bicycle ergometer

193

1326

1.47

6.06

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

574

1.72

6.05

1.3

73.33

66.20

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

207

1443

1.45

6.03

1.6

1.7

1.20

1.19

g/l

0.28

200

1376

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

515

1.76

6.03

1.2

58.46

63.49

u/l

0.31

447

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

109

661

1.66

5.93

1.2

6.17

9.61

u/ml

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

110

1758

0.62

5.91

1.1

0.58

0.62

ratio

0.37

246

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

197

2.24

5.90

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

3.12

5.88

1.9

1.4

0.53

0.49

e9/l

0.24

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

161

1075

1.51

5.83

1.1

1.00

9.51

eliau/ml

3.29

134

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

305

1.98

5.81

1.2

1.3

27.94

23.74

u/l

0.16

251

(3019832) Treponema pallidum Ab [Presence] in Serum

419

3291

1.30

5.78

2.0

1.7

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

435

3438

1.29

5.72

2.6

2.9

146.70

182.85

ng/l

1.38

397

3150

(3010838) Calcium [Moles/time] in 24 hour Urine

133

858

1.56

5.64

1.9

5.53

5.07

mmol/24h

0.84

121

760

(3035320) C reactive protein [Mass/volume] in Body fluid

344

1.90

5.62

4.0

2.5

35.40

28.42

mg/l

0.47

244

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4733

46061

1.23

5.58

5.7

4.9

1.43

1.49

mmol/l

22.23

4393

43062

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

537

1.71

5.50

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

199

1403

1.43

5.50

1.6

1.7

0.24

0.23

g/l

0.49

193

1337

(40768443) Skin Pathology biopsy report

288

2161

1.35

5.49

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

140

920

1.54

5.48

1.6

1.5

—

(3017569) Oxygen content in Arterial blood

211

2.14

5.43

2.0

1.9

14.94

16.20

1.51

211

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

313

1.93

5.42

1.2

1.3

85.42

91.07

u/l

0.22

266

(3024980) IgG subclass 4 [Mass/volume] in Serum

125

803

1.57

5.41

1.4

1.6

0.75

0.82

g/l

0.29

101

622

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

185

1294

1.44

5.34

1.8

2.0

3.58

8.45

iu/l

0.58

540

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

186

1306

1.44

5.27

1.4

3.75

9.75

iu/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

170

1174

1.46

5.25

1.1

1.2

3.05

3.36

0.25

158

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

176

2.22

5.18

1.3

1.4

30.52

29.98

umol/l

0.11

164

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.58

5.16

1.2

—

(3044941) Cell count panel - Synovial fluid

125

813

1.55

5.15

1.6

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

581

1.65

5.06

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

188

1335

1.42

5.02

2.6

2.4

191.61

196.05

0.29

174

1279

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

116

750

1.56

4.92

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

434

1.74

4.91

1.3

1.72

1.41

nmol/l

0.90

384

(3036489) Thrombin time

235

1742

1.36

4.88

2.1

2.0

21.18

21.08

0.06

211

1543

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

228

2.03

4.84

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

429

1.74

4.82

1.0

1.1

—

3.19

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

589

1.62

4.81

1.5

1.3

—

nmol/l

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

144

983

1.48

4.76

2.5

2.4

171.59

99.95

ug/min

0.44

585

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

320

4068

0.77

4.73

1.6

1.7

3.30

3.51

mmol/l

2.61

230

2801

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

192

1385

1.40

4.72

2.9

2.5

3.57

3.55

g/l

0.07

181

1321

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

146

1009

1.46

4.55

1.5

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

370

1.77

4.53

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

207

2.04

4.51

1.1

—

(4024509) Urine culture

276

2126

1.31

4.46

2.1

1.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

447

1.69

4.45

4.7

4.5

6.70

7.11

mmol/l

0.57

377

(3030981) Hyaline casts [#/volume] in Urine by Automated count

460

3775

1.24

4.45

2.3

2.4

0.42

0.44

e6/l

0.11

441

3612

(3035933) Granulocytes/Leukocytes in Blood

138

950

1.46

4.40

3.2

3.5

58.91

57.76

0.49

138

950

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.62

4.39

1.1

0.10

2.18

u/ml

1.21

(3004451) EKG impression Narrative

244

1.93

4.38

1.1

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

294

1.85

4.36

1.0

1.1

240.47

284.69

mg/l

1.26

261

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

197

1448

1.37

4.35

2.3

2.1

91.94

92.36

0.08

190

1408

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

316

1.81

4.35

1.3

1.5

12.45

13.12

umol/l

0.25

300

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

125

2.33

4.33

1.4

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

208

1545

1.36

4.31

2.3

2.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

11.68

4.27

1.9

2.0

215.71

158.83

ug/l

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

304

1.82

4.25

1.1

1.2

35.50

44.16

mg/l

1.15

260

(3023419) Bacteria identified in Sputum by Culture

563

1.59

4.21

2.6

2.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

265

2048

1.31

4.20

1.5

1.8

1.51

1.55

g/l

0.32

225

1775

(4062490) Immunoglobulin typing, IgG

463

1.65

4.18

1.3

—

(3017732) Neutrophils [#/volume] in Blood

692

5949

1.19

4.15

3.1

3.2

4.21

4.50

e9/l

0.99

584

5198

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

184

1351

1.37

4.11

1.4

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

208

1.98

4.10

1.2

1.7

2.14

5.44

nmol/l

1.21

171

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

459

1.64

4.06

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1358

0.65

4.00

1.4

1.6

854.58

1015.69

mu/l

1.29

1126

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

171

1248

1.38

3.98

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

253

1.87

3.97

1.8

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

218

1.93

3.95

1.3

1.2

0.52

0.59

ratio

1.29

135

(37208534) Antinuclear antibody arbitrary concentration in serum

137

2.20

3.94

1.1

1.0

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

194

1448

1.35

3.93

3.9

3.1

0.39

0.33

iu/ml

1.14

781

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

313

1.77

3.89

1.2

1.3

2.11

1.76

u/ml

0.06

183

(3047007) Chlamydophila sp Ab [Presence] in Serum

634

1.52

3.79

1.3

1.2

—

(3025159) Blasts/Leukocytes in Blood

487

4089

1.21

3.79

4.9

4.7

0.06

0.46

1.90

113

1055

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

656

0.52

3.77

1.5

1.6

—

(3021440) Promyelocytes/Leukocytes in Blood

480

4028

1.21

3.76

4.7

4.6

0.10

0.12

0.29

123

1093

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

265

1.82

3.76

1.8

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

288

1.78

3.72

1.3

1.4

146.89

166.75

pmol/l

0.55

288

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

378

1.67

3.71

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

371

1.68

3.69

1.2

—

(3017181) Myelocytes/Leukocytes in Blood

498

4202

1.20

3.69

4.7

4.5

0.80

0.96

0.75

140

1267

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

425

1.63

3.68

3.4

3.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

379

1.67

3.68

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

410

1.64

3.67

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

403

1.65

3.64

1.2

—

(4034850) Laboratory test

186

1397

1.34

3.64

12.3

8.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

560

1.54

3.64

1.5

1.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

513

1.57

3.62

1.1

1.2

—

(3008898) HLA-B27 [Presence]

195

1477

1.33

3.61

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

113

781

1.46

3.60

1.5

1.7

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

329

1.71

3.57

1.0

1.1

3.66

10.06

iu/ml

3.45

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

242

1893

1.29

3.56

3.7

3.8

459.68

3046.94

u/ml

1.07

202

1665

(3019225) pH of Specimen

497

4209

1.20

3.55

3.6

4.3

7.36

0.05

354

2961

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

332

1.69

3.47

1.8

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1475

13557

1.12

3.41

5.5

5.4

1.85

2.72

ug/l

6.67

1321

12430

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

412

1.61

3.37

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

3.10

3.36

1.0

1.2

0.21

0.41

nmol/l

—

(3002179) Metamyelocytes/Leukocytes in Blood

473

4010

1.20

3.35

4.5

4.4

0.65

0.71

0.22

132

1212

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

596

1.50

3.34

1.1

2.11

3.61

eliau/ml

1.12

272

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

170

1278

1.34

3.34

1.6

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

322

1.68

3.29

1.3

1.7

35.43

20.41

u/ml

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

338

1.66

3.27

1.2

1.0

286.16

289.21

mg/l

0.15

313

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

293

1.71

3.25

1.8

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.78

3.25

1.0

1.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

167

1259

1.34

3.23

2.4

2.1

11.52

11.61

mg/l

0.06

153

1171

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

356

1.64

3.18

1.3

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

593

0.54

3.17

1.9

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

281

1.71

3.14

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

499

0.50

3.14

1.4

1.5

55.57

60.88

ug/l

0.31

499

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.41

3.13

1.1

1.3

1.17

mmol/l

0.17

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

397

1.59

3.12

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

397

1.59

3.12

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

216

1.81

3.08

1.1

1.06

1.21

u/l

0.93

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.38

3.05

1.1

0.55

0.67

umol/24h

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

217

1.80

3.04

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

160

1.94

3.03

1.4

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

307

1.67

3.03

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

124

903

1.38

3.01

1.6

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

278

1.70

2.98

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

212

1.80

2.95

2.5

2.0

20.83

114.07

ug/min

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

155

1.94

2.94

2.3

2.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

280

1.68

2.92

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

171

1316

1.31

2.90

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

113

816

1.39

2.90

1.2

1.3

17.25

31.25

u/l

2.45

715

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.44

2.89

1.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

477

1.52

2.89

1.2

1.3

0.43

0.42

g/l

0.06

337

(3028192) IgG subclass 2 [Mass/volume] in Serum

477

1.52

2.89

1.2

1.3

2.73

3.01

g/l

0.84

336

(3027135) IgG subclass 1 [Mass/volume] in Serum

477

1.52

2.89

1.2

1.3

6.19

6.96

g/l

1.54

335

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

1065

1.34

2.88

1.6

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

2.70

2.88

1.2

1.3

58.50

65.60

ug/l

0.94

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1196

10960

1.12

2.86

4.8

4.3

22.19

21.86

0.28

538

5373

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4002

38915

1.11

2.86

27.7

18.4

332.23

332.18

g/l

0.11

3979

38706

(3003329) Lymphocytes/Leukocytes in Synovial fluid

383

1.57

2.85

1.3

1.6

36.24

31.93

0.32

239

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

590

5169

1.16

2.83

3.8

4.6

37.03

34.41

ug/l

0.05

466

4176

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

179

1.85

2.81

1.1

—

334.62

—

(3014271) Vancomycin [Susceptibility]

158

1.90

2.79

3.1

2.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

901

0.65

2.78

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

115

841

1.38

2.76

1.2

520.63

410.14

titre

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

614

1.44

2.75

1.1

1.52

1.53

g/l

0.12

556

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

131

1.99

2.74

1.4

2.3

0.69

1.04

ug/l

0.76

121

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

203

1.78

2.72

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

388

1.55

2.71

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

5081

50212

1.21

2.70

31.5

22.1

253.88

251.60

e9/l

1.75

4998

49172

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.60

2.70

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.50

2.69

1.4

1.5

—

(3020491) Glucose [Moles/volume] in Blood

287

1.64

2.68

1.5

1.8

7.99

6.68

mmol/l

0.89

189

(3032057) Clostridioides difficile [Presence] in Stool

2.33

2.64

1.9

1.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

149

1142

1.31

2.64

2.1

2.2

3918.05

5254.14

u/l

0.19

480

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

266

1.66

2.62

2.1

1.6

4.57

6.52

u/l

2.01

229

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.66

2.62

1.0

—

(3035941) MCH [Entitic mass]

5081

50225

1.21

2.61

31.4

22.0

30.42

30.33

3.46

5033

49714

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5081

50226

1.21

2.60

31.4

22.0

91.42

91.11

5.29

5034

49713

(3010813) Leukocytes [#/volume] in Blood

5082

50239

1.21

2.59

31.6

22.1

6.76

6.62

e9/l

3.54

4981

49037

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

118

877

1.35

2.58

1.2

1.3

276.51

275.69

u/ml

0.01

570

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.60

2.57

1.4

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5081

50231

1.20

2.57

32.2

22.5

40.33

41.24

3.20

5034

49689

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

450

1.50

2.56

2.1

1.9

3104.00

1348.00

titre

—

(3026361) Erythrocytes [#/volume] in Blood

5081

50234

1.20

2.55

31.5

22.1

4.46

4.50

e12/l

9.32

4974

49043

(3016244) Insulin [Units/volume] in Serum or Plasma

193

1.77

2.53

2.6

3.1

20.37

23.66

mu/l

0.36

186

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.42

2.53

1.3

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

509

1.46

2.52

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

178

1407

1.27

2.51

3.0

2.9

1.54

1.56

mg/l

0.10

160

1288

(3000963) Hemoglobin [Mass/volume] in Blood

5081

50245

1.20

2.47

31.8

22.2

134.47

135.68

g/l

7.71

5036

49744

(3006922) Hepatitis E virus Ab [Presence] in Serum

366

1.54

2.44

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

148

1147

1.30

2.44

1.5

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

295

1.60

2.44

1.7

1.6

3.59

6.55

u/l

1.59

242

(3001556) Androgen free Index in Serum or Plasma

3.34

2.39

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

592

1.41

2.35

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.61

2.35

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

396

1.50

2.30

1.3

1.5

72324.40

77579.69

e6/l

0.04

258

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

192

1550

1.25

2.30

1.5

0.90

6.52

iu/ml

0.63

289

(3003888) Timothy IgE Ab [Units/volume] in Serum

102

757

1.35

2.29

1.1

5.41

3.97

u/ml

0.33

381

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

172

1372

1.26

2.28

1.6

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

100

741

1.36

2.27

1.1

40.33

13.50

au/ml

0.69

180

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

456

1.45

2.24

4.6

6.1

20.04

86.14

u/ml

3.02

159

(3023430) Cat dander IgE Ab [Units/volume] in Serum

590

1.40

2.23

1.1

3.30

2.78

u/ml

0.14

253

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.11

2.22

1.8

1.4

40.97

12.84

pmol/l

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

515

1.42

2.22

1.4

1.7

50.67

56.17

0.42

332

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.05

2.21

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.86

2.20

1.9

1.6

1.57

1.38

umol/l

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

100

2.00

2.20

1.3

1.2

330.27

317.70

pmol/l

0.05

(3045424) Erythrocytes [Presence] in Urine

273

2298

1.20

2.18

2.4

2.1

0.00

0.36

estimate

0.54

100

740

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

281

1.57

2.16

1.2

1.4

—

39.00

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.96

2.10

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

160

1.75

2.09

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

114

876

1.31

2.06

1.1

0.92

2.11

u/ml

2.31

449

(21494815) CD4 cells/Lymphocytes in Specimen

374

1.48

2.05

2.2

42.09

38.61

1.04

367

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

703

1.34

2.04

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

115

886

1.30

2.04

1.6

1.4

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

626

0.65

2.02

2.8

2.7

13.35

13.18

0.54

614

(3008401) Mugwort IgE Ab [Units/volume] in Serum

725

1.33

1.97

1.1

1.38

1.10

u/ml

0.18

296

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

120

935

1.29

1.97

1.6

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

691

1.34

1.96

1.1

0.94

1.54

u/ml

0.67

331

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

225

1.60

1.96

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

597

1.36

1.95

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

197

1628

1.22

1.94

1.9

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.45

1.92

1.9

2.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

195

1.64

1.92

4.8

4.6

82.37

60.72

mg/l

0.97

148

(3027456) Digoxin [Moles/volume] in Serum or Plasma

108

833

1.30

1.92

3.6

3.1

0.79

0.82

nmol/l

0.40

669

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

106

1.89

1.90

1.1

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

473

1.40

1.89

1.7

2.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

110

854

1.29

1.87

1.6

1.5

136.51

155.65

au/ml

1.00

252

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

294

1.50

1.81

2.1

2.6

257.03

233.94

e6/l

0.28

251

(40761539) Cells [Type] in Urine sediment by Light microscopy

101

1.88

1.80

1.3

1.1

—

(44813793) Dust mix specific IgE antibody measurement

303

1.49

1.79

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

180

1492

1.21

1.75

1.9

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

354

1.44

1.75

1.2

—

55.54

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

714

1.31

1.74

1.2

3.46

4.44

u/ml

0.54

337

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

132

1.75

1.73

2.3

2.7

154.60

92.73

au/ml

—

(1761482) Bacteria [#/volume] in Urine by Culture

1053

0.76

1.72

4.7

4.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

516

1.36

1.72

1.1

100.09

97.60

0.29

483

(3051611) Lipemic interference index of Serum or Plasma

431

1.40

1.72

2.5

3.4

14.18

12.95

index

0.37

260

(3051387) C reactive protein [Mass/volume] in Capillary blood

960

0.75

1.70

3.4

3.1

25.45

27.82

mg/l

0.22

660

(3013247) Albumin in CSF/Albumin in Serum or Plasma

2.00

1.69

1.0

1.1

8.31

8.73

mg/g

0.07

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

291

1.48

1.69

1.2

1.4

—

357.00

—

(3042631) Mycobacterium sp identified in Specimen

587

1.33

1.68

3.1

2.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

111

877

1.27

1.68

1.4

1.9

0.89

0.86

nmol/l

0.19

757

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

276

1.49

1.66

2.0

2.4

548.44

523.97

e6/l

0.12

224

(3024869) Neuronal Ab [Presence] in Serum

2.10

1.65

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.10

1.65

2.0

1.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.80

1.65

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

244

1.52

1.64

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.93

1.64

1.0

1.1

26.94

33.94

iu/ml

0.20

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

127

1024

1.25

1.63

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

146

1196

1.23

1.62

1.6

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

197

1.58

1.62

1.5

1.7

2.77

3.93

u/field

0.28

126

(3044242) Glucose [Moles/volume] in Arterial blood

213

1.55

1.61

1.5

1.7

7.04

8.17

mmol/l

1.45

213

(3013762) Body weight Measured

3.57

1.61

1.0

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

306

2677

1.15

1.60

3.1

4.0

39.93

62.89

u/ml

1.35

296

2588

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

113

1.77

1.60

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

506

1.35

1.59

1.3

1.4

36389.70

44882.10

e6/l

0.20

272

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

206

1.56

1.59

4.2

4.1

—

(3011412) CD3 cells [#/volume] in Blood

413

1.38

1.58

2.3

1360.96

1147.65

e6/l

0.88

366

(3005988) Vibrio sp identified in Specimen by Organism specific culture

525

1.34

1.57

1.2

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

525

1.34

1.57

1.2

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

483

0.66

1.56

2.4

2.1

1.19

1.20

mmol/l

0.55

475

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

701

1.29

1.55

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

122

1.72

1.54

1.2

1.1

96.17

85.32

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.43

1.53

1.0

1.2

11.75

19.03

u/l

—

(3000012) Reticulocyte production index

632

1.30

1.53

3.0

2.2

0.86

0.90

0.26

429

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.59

1.51

1.0

—

(3012565) Volume of 24 hour Urine

217

1.52

1.51

1.8

2.3

1796.75

1877.57

0.23

197

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.43

1.47

2.7

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

778

0.74

1.47

1.3

1.5

63.27

58.86

ug/l

0.19

638

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

540

1.32

1.46

1.3

1.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

672

1.28

1.46

1.1

122.65

117.05

0.76

609

(3017509) Phencyclidine [Presence] in Urine

2.50

1.45

2.6

1.1

—

(40768793) Breast Pathology biopsy report

150

1249

1.21

1.45

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

550

1.31

1.44

1.3

1.4

—

(4038314) Semen analysis, post vasectomy

3.13

1.44

1.2

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

319

1.41

1.43

1.9

2.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.97

1.43

2.6

1.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

589

1.29

1.38

2.0

2.4

1.53

1.21

g/24h

0.42

354

(3041354) Potassium [Moles/volume] in Venous blood

492

0.69

1.37

2.3

2.1

4.02

4.04

mmol/l

0.14

484

(3035285) Chloride [Moles/volume] in Venous blood

492

0.69

1.37

2.3

2.1

104.15

105.50

mmol/l

0.86

484

(3024522) Salmonella sp identified in Specimen by Organism specific culture

546

1.30

1.37

1.3

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

373

1.37

1.2

1.3

9.19

8.79

mmol/l

0.19

356

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

121

0.41

1.37

1.4

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.80

1.37

1.7

1.3

0.34

0.41

mmol/l

—

(3016750) Collection duration of Urine

231

1.47

1.36

2.6

2.3

492.48

500.72

min

0.18

173

(3014133) Dog dander IgE Ab [Units/volume] in Serum

627

1.28

1.35

1.1

1.69

2.72

u/ml

0.50

304

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

523

1.30

1.32

2.3

2.2

18.81

23.45

mg/l

0.49

188

(3025468) Yersinia sp identified in Specimen by Organism specific culture

523

1.30

1.32

1.2

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

113

1.68

1.31

1.1

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.74

1.30

1.1

1.0

—

(3012898) Urea [Moles/volume] in Urine

2.09

1.30

1.3

1.4

203.89

156.97

mmol/l

—

(4146454) Self-monitoring of blood glucose

464

1.32

1.29

2.5

2.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.35

1.29

1.4

1.1

6.64

6.28

mmol/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

354

0.65

1.28

1.3

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

114

1.67

1.28

1.4

2.0

0.16

0.15

e9/l

0.10

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.29

1.26

2.1

1.7

34.38

49.77

umol/l

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

724

0.76

1.26

1.3

1.5

1.11

1.09

ratio

0.05

437

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

207

1798

1.16

1.26

2.1

1.9

1.17

2.19

ug/l

1.25

187

1619

(4015189) Microbial culture of sputum

1.74

1.24

2.0

2.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

406

1.33

1.24

2.3

2.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

346

1.36

1.24

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

181

1559

1.17

1.23

3.2

3.6

49.45

52.71

mg/l

0.12

154

1350

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

304

1.38

1.23

1.1

12.94

20.75

u/ml

—

116

(4195642) Thrombophilia screening test

681

1.25

1.22

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

2.16

1.21

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

883

8307

1.08

1.20

3.3

3.2

0.65

0.77

ug/l

3.93

611

5332

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

297

1.38

1.20

1.9

1.8

91.31

114.51

ng/l

1.15

297

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

721

1.24

1.17

1.3

1.2

1.97

3.21

u/ml

0.81

259

(3029634) Reagin Ab [Titer] in Serum by VDRL

569

1.27

1.17

2.9

2.2

2.50

10.59

titre

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.93

1.17

1.1

1.0

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

1.16

0.0

1.1

—

4.74

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

1.16

0.0

4.8

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

1.16

0.0

5.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

724

0.77

1.15

1.3

1.5

1.12

0.96

ratio

2.29

437

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

724

0.77

1.15

1.3

1.5

1.17

1.14

ratio

0.09

440

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

535

1.27

1.15

1.0

0.59

0.26

u/ml

0.24

157

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

118

1.61

1.14

1.3

110.20

84.81

—

(3022621) pH of Urine by Test strip

402

3667

1.10

1.13

2.7

2.5

6.09

6.04

0.63

275

2481

(3050794) Legionella sp Ab [Presence] in Serum

2.00

1.12

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

416

4543

0.91

1.12

1.4

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

159

1.51

1.11

3.3

9.38

8.79

mg/l

0.15

133

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

179

1557

1.15

1.10

3.2

3.6

30.17

57.25

mg/l

1.92

152

1347

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

106

883

1.20

1.09

3.6

3.7

34.09

34.49

u/ml

0.01

101

858

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.95

1.08

1.6

1.3

—

(40762887) Creatinine [Moles/volume] in Blood

2.19

1.08

1.6

1.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.19

1.08

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

166

0.54

1.07

1.0

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

501

0.74

1.07

1.1

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

112

940

1.20

1.07

1.6

1.4

—

18.60

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.92

1.06

1.0

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

714

0.78

1.05

1.3

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

195

1.44

1.04

1.0

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

160

1388

1.16

1.03

3.2

3.5

2.82

2.38

ratio

0.12

808

(3043238) Trisomy 21 risk [Likelihood] in Fetus

611

0.77

1.03

1.4

1.5

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.06

1.02

1.7

3.0

1.29

0.44

u/field

—

(3023199) Leukocytes [#/volume] in Pleural fluid

572

1.24

1.01

1.3

1.4

17015.50

3786.55

e6/l

0.43

394

(3047352) Trisomy 18 risk [Likelihood] in Fetus

598

0.77

1.01

1.3

1.5

—

(3037121) Protein [Mass/volume] in Urine

176

1542

1.15

1.00

3.3

188.11

504.83

mg/l

3.69

677

(3045788) Cell count panel - Pleural fluid

475

1.27

1.00

1.3

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.00

1.00

1.1

1.47

1.72

umol/24h

—

(3001019) Free T4 and TSH panel - Serum or Plasma

241

2157

1.12

0.99

1.8

1.7

—

(3012441) Differential panel - Pleural fluid

477

1.26

0.97

1.2

1.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

258

1.36

0.96

1.2

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.89

0.94

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

1.52

0.93

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

1.61

0.93

1.3

1.4

109.13

52.01

mu/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

453

1.26

0.93

1.3

1.4

6.09

6.31

mmol/l

0.18

422

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.22

0.93

1.2

1.3

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.22

0.93

1.2

1.3

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.75

0.90

1.1

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

2.07

0.89

1.3

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

127

1.50

0.88

1.3

1.7

10.18

9.11

ug/l

0.40

127

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

205

0.63

0.87

1.0

1.1

11.69

11.03

mm/h

0.07

205

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.00

0.87

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.00

0.87

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

195

1741

1.12

0.86

1.3

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.56

0.84

1.1

—

(3010503) CD19 cells [#/volume] in Blood

265

1.32

0.84

2.8

2.4

132.03

264.78

e6/l

0.46

258

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

371

1.27

0.83

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

371

1.27

0.83

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

371

1.27

0.83

1.5

1.7

—

(3020874) Milk IgE Ab [Units/volume] in Serum

257

1.33

0.82

1.1

1.56

1.91

u/ml

—

(3044009) aPTT.lupus sensitive (LA screen)

1.88

0.81

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

337

1.28

0.81

1.5

1.7

—

(3037756) Immunofixation for Serum or Plasma

108

931

1.16

0.81

1.5

1.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

232

1.34

0.81

1.2

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.79

0.0

1.1

—

(4212803) Bone marrow aspirate examination

1.82

0.79

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

286

1.30

0.78

2.0

1.4

79.41

79.55

umol/l

0.01

286

(3005033) Fetal Nuchal fold Thickness US

585

0.80

0.78

1.3

1.4

1.33

1.28

0.40

412

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.56

0.78

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

151

1339

1.13

0.77

1.3

179.72

219.26

miu/ml

0.71

620

(3003434) Protein [Mass/volume] in Pleural fluid

649

1.19

0.76

1.3

1.4

35.74

32.88

g/l

1.34

582

(3014599) Egg white IgE Ab [Units/volume] in Serum

252

1.31

0.76

1.1

1.0

0.90

0.38

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.64

0.75

1.3

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

108

1.48

0.73

1.1

—

13.67

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

108

1.48

0.73

1.3

47.73

35.83

0.43

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.00

0.72

1.0

1.1

—

26.86

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

1.61

0.72

7.1

6.4

67.56

47.32

ug/min

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

571

1.19

0.71

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.92

0.70

1.4

1.3

—

(4211845) Urine protein measurement

221

1.31

0.69

2.9

3.4

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

1.79

0.66

1.0

1.5

2.84

0.29

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.72

0.64

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.72

0.64

2.0

1.4

278.60

346.45

umol/24h

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1.27

0.63

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

332

1.24

0.63

2.6

2.3

748.11

648.44

0.47

217

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.50

0.63

1.5

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

479

1.19

0.62

1.3

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

199

0.70

0.61

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

226

1.28

0.61

1.2

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

226

1.28

0.61

1.2

1.6

—

(3003694) ABO and Rh group [Type] in Blood

1311

13500

0.96

0.60

1.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.60

0.0

1.1

—

1.14

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

151

0.66

0.59

1.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.58

0.0

1.2

—

2.22

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

170

1859

0.91

0.56

4.2

5.3

0.84

0.88

0.64

162

1748

(3002619) Bacteria identified in Specimen by Culture

1.43

0.56

1.4

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.46

0.56

1.1

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.54

0.55

1.4

1.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.50

0.54

1.1

23.64

6.12

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

580

1.16

0.54

5.5

6.5

11.80

12.06

mg/l

0.18

541

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.48

0.53

1.9

2.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

153

1.31

0.50

1.0

—

(3033099) Centromere Ab [Titer] in Serum

118

1.36

0.50

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

288

1.22

0.50

1.6

1.5

—

(3006462) Nitrate [Presence] in Urine

207

1.26

0.49

2.8

3.5

—

(3047181) Lactate [Moles/volume] in Blood

142

1298

1.10

0.49

4.0

6.2

1.19

1.30

mmol/l

1.39

128

1138

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.49

0.47

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.46

0.46

1.0

1.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.43

0.46

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

129

1.32

0.45

2.2

3.0

4.93

4.77

kpa

0.28

129

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

238

1.22

0.44

1.1

1613.17

1517.08

miu/ml

0.21

238

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

130

1.31

0.43

2.2

3.0

11.31

10.48

kpa

0.56

130

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

131

0.69

0.43

1.4

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

151

0.73

0.42

1.0

1.1

—

(44806420) Estimation of glomerular filtration rate

542

0.87

0.42

3.5

2.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.1

—

(3024263) Appearance of Synovial fluid

223

1.21

0.39

1.6

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.39

0.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

381

1.16

0.39

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

124

1.29

0.38

2.1

1.8

—

(3001729) Color of Synovial fluid

1.39

0.38

1.0

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.39

0.38

2.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

549

5685

0.96

0.37

5.3

4.9

31.04

32.84

3.49

383

3764

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

515

0.87

0.37

4.2

4.0

26.50

56.52

u/ml

2.19

510

(42529582) MDA5 Ab [Presence] in Serum by Line blot

134

1.27

0.36

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

134

1.27

0.36

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

134

1.27

0.36

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

134

1.27

0.36

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.27

0.36

1.0

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

263

1.18

0.35

2.8

2.7

37.43

39.34

0.21

140

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.65

0.35

1.4

1.6

—

(4268621) Lupus anticoagulant assay

527

1.12

0.35

2.6

2.2

—

(40768806) Pleura Pathology biopsy report

480

1.13

0.34

1.3

1.5

—

(40768446) Kidney Pathology biopsy report

181

1.22

0.34

1.2

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

191

1.21

0.33

1.2

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

191

1.21

0.33

1.2

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

117

1086

1.08

0.33

3.0

3.8

255.18

410.99

u/ml

0.47

104

984

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

253

0.83

0.33

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.28

0.32

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

191

2018

0.94

0.32

4.2

5.1

1.76

1.58

1.35

183

1902

(3000034) Microalbumin [Mass/volume] in Urine

401

0.87

0.31

3.6

2.9

10.85

70.05

mg/l

2.24

289

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

580

1.10

0.31

1.3

1.2

7.57

7.41

mmol/l

0.15

510

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

113

1052

1.08

0.30

3.8

5.7

223.85

455.29

iu/ml

0.87

142

(3006576) Bicarbonate [Moles/volume] in Blood

142

0.77

0.30

2.7

6.5

26.17

25.17

mmol/l

0.19

131

(3034274) Bile acid [Moles/volume] in Serum --fasting

390

1.13

0.30

1.5

2.1

4.36

9.06

umol/l

2.11

283

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.29

0.30

2.0

3.1

28.58

43.40

1.86

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

1.29

0.30

4.0

6.2

13.42

8.32

1.53

(4133840) Spirometry

130

0.77

0.29

1.0

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

373

1.13

0.29

1.2

115.48

111.81

pmol/l

0.20

373

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.27

0.27

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.27

0.27

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.27

0.27

1.3

—

(3017704) Immunofixation for Urine

237

0.84

0.27

1.8

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

140

1.21

0.27

1.1

—

5.20

—

(3048879) Bone marrow aspiration report

120

0.75

0.27

1.1

2.1

—

2.00

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

788

1.08

0.27

1.4

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

268

0.86

0.26

1.1

1.2

1.14

1.06

ratio

0.79

215

(40768441) Liver Pathology biopsy report

370

1.11

0.23

1.7

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.32

0.23

1.0

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

237

1.14

0.23

1.0

2.33

1.81

u/ml

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

237

1.14

0.23

9.0

5.6

33.60

17957.30

u/ml

—

(3044007) Cell count panel - Peritoneal fluid

168

0.83

0.22

1.9

1.8

—

(44790048) Parainfluenza type 2 nucleic acid detection

592

1.08

0.22

1.4

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

592

1.08

0.22

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

592

1.08

0.22

1.4

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

592

1.08

0.22

1.4

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.22

0.22

1.0

1.1

0.03

0.02

u/ml

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

178

0.84

0.22

1.1

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

439

1.09

0.22

1.6

1.4

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.19

0.21

1.2

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.21

0.0

2.3

—

0.13

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

2.62

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

0.21

0.0

11.2

—

60.60

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

1.16

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

759

1.07

0.21

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

12.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

1.83

—

(3008536) Aspergillus sp Ab [Presence] in Serum

101

0.79

0.21

1.3

2.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.16

0.21

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

387

0.90

0.20

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

166

0.84

0.20

1.7

366.83

24253.89

e6/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

123

0.81

0.20

1.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.20

0.0

1.2

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.4

—

96.14

—

(3020650) Glucose [Presence] in Urine

175

0.86

0.18

1.7

1.4

0.20

0.05

estimate

0.32

175

(4035726) Immunohistochemistry procedure

456

4460

1.02

0.18

1.3

1.4

—

(3014891) Appearance of Pleural fluid

1.19

0.18

1.1

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

387

1.09

0.17

1.7

1.5

3.06

4.57

ug/l

0.76

307

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

195

1.13

0.17

1.8

3.3

1.05

1.29

0.42

195

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

110

1.18

0.17

1.5

2.0

1.48

2.29

ug/l

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

205

0.88

0.17

1.3

1.6

9.95

7.88

mmol/l

1.69

200

(3044927) Protein electrophoresis panel - Urine

456

1.08

0.16

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

883

0.95

0.15

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

188

1.12

0.14

2.5

2.0

28.76

31.05

0.30

188

(3001964) Herpes simplex virus Ag [Presence] in Specimen

131

1.15

0.14

1.3

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

128

1234

1.04

0.14

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

208

1.11

0.14

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

441

1.07

0.13

1.4

1.8

—

(3018572) Chloride [Moles/volume] in Blood

908

0.96

0.13

4.7

7.4

105.89

105.30

mmol/l

0.66

807

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.17

0.13

1.2

1.5

—

106.80

titre

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

113

1.15

0.13

1.2

1.4

16.49

21.18

0.50

104

(3023487) Leukocytes [#/volume] in Peritoneal fluid

190

0.89

0.13

1.6

1.9

33920.80

4882.68

e6/l

—

131

(3039000) Anion gap in Blood by calculation

907

0.96

0.12

4.7

7.4

11.01

11.27

mmol/l

0.40

805

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

697

1.05

0.12

1.1

1.25

1016.72

iu/ml

0.58

137

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

220

1.09

0.11

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

220

1.09

0.11

1.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

220

1.09

0.11

1.4

1.9

—

(3000330) Specific gravity of Urine by Test strip

226

2309

0.98

0.11

3.2

3.3

1.02

ratio

0.88

199

2102

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

221

1.09

0.11

1.4

1.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

338

1.07

0.10

1.5

1.8

2.32

1.56

u/field

0.36

172

(3003740) Influenza virus B Ag [Presence] in Specimen

839

0.96

0.09

1.1

—

(3042733) HLA Ab [Presence] in Serum

164

1.10

0.09

4.4

5.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.15

0.09

1.0

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

196

0.92

0.09

1.2

1.7

41.69

40.14

g/l

0.52

196

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.11

0.09

1.2

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.09

0.08

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

134

0.90

0.08

1.2

—

(44806071) Cardiolipin IgM antibody measurement

1.07

0.08

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.05

0.08

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

117

1.11

0.08

1.5

1.9

—

(40757373) Influenza virus identified in Isolate

1.05

0.07

1.6

—

(4281824) Cell count and differential, peritoneal fluid

600

0.97

0.07

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.03

0.07

1.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

266

1.05

0.06

1.2

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

436

1.03

0.04

4.5

4.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

835

0.98

0.04

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

131

1.07

0.03

1.1

1.2

9.79

11.83

pmol/l

—

(3035880) pH of Pleural fluid

240

1.04

0.03

1.4

1.3

7.33

7.42

0.49

170

(21494434) Karyotype in Bone marrow

421

0.97

0.03

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

261

1.03

0.02

1.2

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

127

0.94

0.01

1.2

2.0

13.61

45.16

u/l

1.14

119

(3024932) HLA-DR beta [Type]

143

1.05

0.01

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

337

0.98

0.01

8.1

7.2

3.94

76.58

ug/l

0.97

219

(3017354) Segmented neutrophils/Leukocytes in Blood

487

0.99

0.01

4.0

4.1

56.08

57.43

0.17

428

(3045142) Bone marrow Pathology biopsy report

583

1.01

0.01

1.3

1.4

—

(3034426) Prothrombin time (PT)

156

0.96

0.00

1.2

1.1

28.67

28.74

0.02

156

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

182

0.99

0.00

1.3

1.6

—

(3047189) Immunofixation for 24 hour Urine

218

1.01

0.00

1.4

2.0

—

(3004809) Band form neutrophils/Leukocytes in Blood

765

0.99

0.00

3.6

3.9

1.50

1.60

0.09

688

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

775

0.99

0.00

1.5

1.6

—

(40758292) HTLV I+II Ab panel - Serum

1.04

0.00

1.0

1.4

—

(40765096) Chromosome analysis panel by Banding

146

1.03

0.00

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

174

0.98

0.00

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

107

1.03

0.00

3.8

2.3

7.36

337.06

ug/l

0.66

107

(3027923) C peptide [Moles/volume] in Serum or Plasma

236

1.02

0.00

1.5

1.4

0.95

1.32

nmol/l

1.65

169

(3028433) Virus identified in Specimen by Culture

133

0.98

0.00

1.1

1.2

—

(3013727) Leukocytes other/Leukocytes in Blood

143

0.98

0.00

2.8

3.6

52.60

51.28

0.08

135

(3024471) HLA-A [Type]

147

1.02

0.00

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

177

1.02

0.00

2.9

2.7

0.59

0.61

mmol/l

0.46

177

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

406

1.01

0.00

1.5

—

(40768795) Lymph node Pathology biopsy report

526

1.01

0.00

1.4

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

0.99

0.00

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

159

1.01

0.00

1.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

159

1.01

0.00

1.6

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

161

0.99

0.00

1.6

2.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.4

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.4

—

23.09

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

120.60

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.0

—

45.80

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.90

0.00

2.0

3.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

11353.60

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.88

-0.00

1.0

1.1

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

33.49

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.00

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.94

-0.00

1.4

1.5

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.25

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.94

-0.00

1.2

1.1

—

(3009992) Blasts/cells in Bone marrow

0.00

-0.00

0.0

2.4

—

2.86

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

13.99

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MAOI_A – Monoamine oxidase A inhibitors

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Monoamine oxidase A inhibitors

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Case counts by code for Monoamine oxidase A inhibitors (MAOI_A)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints